Protein Type,Mutation,PMID,Source,Drug,Mutation_x,Resistance_level,Mutation_y,Protein,Original Site,Original protein type,HA_Type
N1,116A,PMID:31228489,"The susceptibility of CA/04NA−V116A mutant to oseltamivir and zanamivir was reduced (meanIC50 increase: 10.0- and 17.4-fold, respectively) as compared to that of the wild-type CA/04 virus.",oseltamivir,,low,,N2,116A,N1,
N1,116A,PMID:31228489,"The susceptibility of CA/04NA−V116A mutant to oseltamivir and zanamivir was reduced (meanIC50 increase: 10.0- and 17.4-fold, respectively) as compared to that of the wild-type CA/04 virus.",zanamivir,,middle,,N2,116A,N1,
N1,116A,PMID:31228489,"The susceptibility of CA/04NA−V116A mutant to oseltamivir and zanamivir was reduced (meanIC50 increase: 10.0- and 17.4-fold, respectively) as compared to that of the wild-type CA/04 virus.",laninamivir,,low,,N2,116A,N1,
N1,117R,PMID:28802866,Table 1 of the original text mentions that the NA substitution I117R reduced sensitivity to zanamivir (10.0-fold).,zanamivir,,low,,N2,117R,N1,
N1,117V,PMID:31228489,The CA-NAI117V virus exhibited reduced sensitivity to oseltamivirand zanamivir in virus reduction assay in Calu-3 cells.,oseltamivir,,low,,N2,117V,N1,
N1,117V,PMID:31228489,The CA-NAI117V virus exhibited reduced sensitivity to oseltamivirand zanamivir in virus reduction assay in Calu-3 cells.,zanamivir,,low,,N2,117V,N1,
N1,119A,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",oseltamivir,,middle,,N2,119A,N1,
N1,119A,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",zanamivir,,high,,N2,119A,N1,
N1,119A,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",laninamivir,,high,,N2,119A,N1,
N1,119A,PMID:24957832,"The E119A NA substitution conferred reduced susceptibility to laninamivir, zanamivir, oseltamivir, and peramivir with 82-, 90-, 17-, and 12-fold increases in IC50s, respectively, compared with those of the WT virus. A recombinant A(H1N1)pdm09 (A/Quebec/144147/2009) virus harboring E119K NA and K133E HA substitutions was also generated by reverse genetics.",oseltamivir,,middle,,N2,119A,N1,
N1,119A,PMID:24957832,"The E119A NA substitution conferred reduced susceptibility to laninamivir, zanamivir, oseltamivir, and peramivir with 82-, 90-, 17-, and 12-fold increases in IC50s, respectively, compared with those of the WT virus. A recombinant A(H1N1)pdm09 (A/Quebec/144147/2009) virus harboring E119K NA and K133E HA substitutions was also generated by reverse genetics.",zanamivir,,middle,,N2,119A,N1,
N1,119A,PMID:24957832,"The E119A NA substitution conferred reduced susceptibility to laninamivir, zanamivir, oseltamivir, and peramivir with 82-, 90-, 17-, and 12-fold increases in IC50s, respectively, compared with those of the WT virus. A recombinant A(H1N1)pdm09 (A/Quebec/144147/2009) virus harboring E119K NA and K133E HA substitutions was also generated by reverse genetics.",peramivir,,middle,,N2,119A,N1,
N1,119A,PMID:24957832,"The E119A NA substitution conferred reduced susceptibility to laninamivir, zanamivir, oseltamivir, and peramivir with 82-, 90-, 17-, and 12-fold increases in IC50s, respectively, compared with those of the WT virus. A recombinant A(H1N1)pdm09 (A/Quebec/144147/2009) virus harboring E119K NA and K133E HA substitutions was also generated by reverse genetics.",laninamivir,,middle,,N2,119A,N1,
N1,119A,PMID:24957832,"The E119A NA substitution conferred reduced susceptibility to laninamivir, zanamivir, oseltamivir, and peramivir with 82-, 90-, 17-, and 12-fold increases in IC50s, respectively, compared with those of the WT virus. A recombinant A(H1N1)pdm09 (A/Quebec/144147/2009) virus harboring E119K NA and K133E HA substitutions was also generated by reverse genetics.",laninamivir,,middle,,N2,119A,N1,
N1,119D,PMID:30602610,"In NAI susceptibility tests, the E119D mutation conferred reduced inhibition by oseltamivir (a 95-fold increase in the 50% inhibitory concentration [IC50]) and highly reduced inhibition by zanamivir, peramivir. and laninamivir (2,660-fold, 460-fold, and 651-fold increases in the IC50s, respectively).",oseltamivir,,high,,N2,119D,N1,
N1,119D,PMID:30602610,"In NAI susceptibility tests, the E119D mutation conferred reduced inhibition by oseltamivir (a 95-fold increase in the 50% inhibitory concentration [IC50]) and highly reduced inhibition by zanamivir, peramivir. and laninamivir (2,660-fold, 460-fold, and 651-fold increases in the IC50s, respectively).",zanamivir,,high,,N2,119D,N1,
N1,119D,PMID:30602610,"In NAI susceptibility tests, the E119D mutation conferred reduced inhibition by oseltamivir (a 95-fold increase in the 50% inhibitory concentration [IC50]) and highly reduced inhibition by zanamivir, peramivir. and laninamivir (2,660-fold, 460-fold, and 651-fold increases in the IC50s, respectively).",peramivir,,high,,N2,119D,N1,
N1,119D,PMID:30602610,"In NAI susceptibility tests, the E119D mutation conferred reduced inhibition by oseltamivir (a 95-fold increase in the 50% inhibitory concentration [IC50]) and highly reduced inhibition by zanamivir, peramivir. and laninamivir (2,660-fold, 460-fold, and 651-fold increases in the IC50s, respectively).",laninamivir,,high,,N2,119D,N1,
N1,119G,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir. Table 1 of the original text mentions that the NA mutation rg-E119G reduced sensitivity to oseltamivir (5.5-fold), zanamivir (292.5-fold) and peramivir (78.8-fold) and laninamivir (112.3-fold).",oseltamivir,,low,,N2,119G,N1,
N1,119G,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir. Table 1 of the original text mentions that the NA mutation rg-E119G reduced sensitivity to oseltamivir (5.5-fold), zanamivir (292.5-fold) and peramivir (78.8-fold) and laninamivir (112.3-fold).",zanamivir,,high,,N2,119G,N1,
N1,119G,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir. Table 1 of the original text mentions that the NA mutation rg-E119G reduced sensitivity to oseltamivir (5.5-fold), zanamivir (292.5-fold) and peramivir (78.8-fold) and laninamivir (112.3-fold).",peramivir,,middle,,N2,119G,N1,
N1,119G,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir. Table 1 of the original text mentions that the NA mutation rg-E119G reduced sensitivity to oseltamivir (5.5-fold), zanamivir (292.5-fold) and peramivir (78.8-fold) and laninamivir (112.3-fold).",laninamivir,,high,,N2,119G,N1,
N1,136K,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir.Table 1 of the original text mentions that the NA mutation rg-Q136K reduced sensitivity to zanamivir (105.1-fold),peramivir (88.1-fold) and laninamivir (38.6-fold).",zanamivir,,high,,N2,136K,N1,
N1,136K,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir.Table 1 of the original text mentions that the NA mutation rg-Q136K reduced sensitivity to zanamivir (105.1-fold),peramivir (88.1-fold) and laninamivir (38.6-fold).",peramivir,,middle,,N2,136K,N1,
N1,136K,PMID:30602610,"The E119G and Q136K mutations conferred mainly reduced to highly reduced inhibition by zanamivir, peramivir, and laninamivir, but the viruses with these mutations remained susceptible to oseltamivir.Table 1 of the original text mentions that the NA mutation rg-Q136K reduced sensitivity to zanamivir (105.1-fold),peramivir (88.1-fold) and laninamivir (38.6-fold).",laninamivir,,middle,,N2,136K,N1,
N1,136L,PMID:20603155,"Of these, one isolate(contains the Q136L NA mutation) demonstrated a significantly raised zanamivir IC50 (218.9 ± 19.6 nM; mean IC50 ± standard deviation) that was approximately 350-fold higher than the other A(H5N1) isolates tested (0.6 ± 0.1 nM; mean IC50 ± standard deviation) (Table 3). The same isolate also demonstrated a more moderate 26-fold increase in oseltamivir IC50 (Table 3).",oseltamivir,,middle,,N2,136L,N1,
N1,136L,PMID:20603155,"Of these, one isolate(contains the Q136L NA mutation) demonstrated a significantly raised zanamivir IC50 (218.9 ± 19.6 nM; mean IC50 ± standard deviation) that was approximately 350-fold higher than the other A(H5N1) isolates tested (0.6 ± 0.1 nM; mean IC50 ± standard deviation) (Table 3). The same isolate also demonstrated a more moderate 26-fold increase in oseltamivir IC50 (Table 3).",zanamivir,,high,,N2,136L,N1,
N1,136R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution Q136R exhibits reduced sensitivity to zanamivir (48–142-fold), peramivir (41–162-fold) and laninamivir (7.7–15-fold).",zanamivir,,middle,,N2,136R,N1,
N1,136R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution Q136R exhibits reduced sensitivity to zanamivir (48–142-fold), peramivir (41–162-fold) and laninamivir (7.7–15-fold).",peramivir,,middle,,N2,136R,N1,
N1,136R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution Q136R exhibits reduced sensitivity to zanamivir (48–142-fold), peramivir (41–162-fold) and laninamivir (7.7–15-fold).",laninamivir,,low,,N2,136R,N1,
N1,136R,PMID:28802866,Table 1 of the original text mentions that the NA substitution Q136R/Q mix reduced sensitivity to zanamivir (20.0-fold).,zanamivir,,middle,,N2,136R,N1,
N1,148A,PMID:32004620,"NA T148A and NA I427T variants showed borderline RI by zanamivir or RI by oseltamivir and zanamivir and borderline RI by laninamivir, respectively.",oseltamivir,,low,,N2,148A,N1,
N1,148A,PMID:32004620,"NA T148A and NA I427T variants showed borderline RI by zanamivir or RI by oseltamivir and zanamivir and borderline RI by laninamivir, respectively.",zanamivir,,middle,,N2,148A,N1,
N1,149A,PMID:21343450,"however, we identified a virus with a mildly decreased sensitivity to zanamivir and have predicted that a V149A mutation is responsible.",zanamivir,,low,,N2,149A,N1,
N1,151D,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",oseltamivir,,middle,,N2,151D,N1,
N1,151D,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",zanamivir,,middle,,N2,151D,N1,
N1,151D,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",peramivir,,low,,N2,151D,N1,
N1,151D,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",laninamivir,,low,,N2,151D,N1,
N1,151N,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",oseltamivir,,middle,,N2,151N,N1,
N1,151N,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",zanamivir,,middle,,N2,151N,N1,
N1,151N,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",peramivir,,low,,N2,151N,N1,
N1,151N,PMID:28802866,"Table 1 of the original text mentions that the NA substitution D151N/D mix reduced sensitivity to oseltamivir (22.0-fold), zanamivir (21.0-fold), peramivir (2.8-fold) and laninamivir (2.9-fold).",laninamivir,,low,,N2,151N,N1,
N1,152K,PMID:30602610,"The R152K mutant remained susceptible to peramivir, but the R152K mutation conferred reduced inhibition by other NAIs.Table 1 of the original text mentions that the NA mutation rg-R152K reduced sensitivity to oseltamivir (42.6-fold), zanamivir (11.9-fold), peramivir (7.3-fold), and laninamivir (15.5-fold).",oseltamivir,,middle,,N2,152K,N1,
N1,152K,PMID:30602610,"The R152K mutant remained susceptible to peramivir, but the R152K mutation conferred reduced inhibition by other NAIs.Table 1 of the original text mentions that the NA mutation rg-R152K reduced sensitivity to oseltamivir (42.6-fold), zanamivir (11.9-fold), peramivir (7.3-fold), and laninamivir (15.5-fold).",zanamivir,,middle,,N2,152K,N1,
N1,152K,PMID:30602610,"The R152K mutant remained susceptible to peramivir, but the R152K mutation conferred reduced inhibition by other NAIs.Table 1 of the original text mentions that the NA mutation rg-R152K reduced sensitivity to oseltamivir (42.6-fold), zanamivir (11.9-fold), peramivir (7.3-fold), and laninamivir (15.5-fold).",peramivir,,low,,N2,152K,N1,
N1,152K,PMID:30602610,"The R152K mutant remained susceptible to peramivir, but the R152K mutation conferred reduced inhibition by other NAIs.Table 1 of the original text mentions that the NA mutation rg-R152K reduced sensitivity to oseltamivir (42.6-fold), zanamivir (11.9-fold), peramivir (7.3-fold), and laninamivir (15.5-fold).",laninamivir,,middle,,N2,152K,N1,
N1,155H,PMID:33202972,"Analysis of residues involved in IAV resistance to antiviral drugs identified only two H1avN1 strains that each naturally acquired a mutation, assessed to impact the efficacy of NA inhibitors, NA-Y155H classified as highly reduced inhibition (HRI) to oseltamivir and zanamivir, and NA-S247N classified as reduced inhibition (RI) to oseltamivir for H5N1 viruses(WHO).",oseltamivir,,high,,N2,155H,N1,
N1,155H,PMID:33202972,"Analysis of residues involved in IAV resistance to antiviral drugs identified only two H1avN1 strains that each naturally acquired a mutation, assessed to impact the efficacy of NA inhibitors, NA-Y155H classified as highly reduced inhibition (HRI) to oseltamivir and zanamivir, and NA-S247N classified as reduced inhibition (RI) to oseltamivir for H5N1 viruses(WHO).",zanamivir,,high,,N2,155H,N1,
N1,198E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-D199E reduced sensitivity to oseltamivir (26.3-fold), zanamivir (8.2-fold), peramivir (3.0-fold), and laninamivir (2.3-fold).",oseltamivir,,middle,,N2,199E,N1,
N1,198E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-D199E reduced sensitivity to oseltamivir (26.3-fold), zanamivir (8.2-fold), peramivir (3.0-fold), and laninamivir (2.3-fold).",zanamivir,,low,,N2,199E,N1,
N1,198E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-D199E reduced sensitivity to oseltamivir (26.3-fold), zanamivir (8.2-fold), peramivir (3.0-fold), and laninamivir (2.3-fold).",peramivir,,low,,N2,199E,N1,
N1,198E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-D199E reduced sensitivity to oseltamivir (26.3-fold), zanamivir (8.2-fold), peramivir (3.0-fold), and laninamivir (2.3-fold).",laninamivir,,low,,N2,199E,N1,
N1,198E,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation D199E shows reduced sensitivity to oseltamivir (16-fold) and zanamivir (7.1-fold).,oseltamivir,,middle,,N2,199E,N1,
N1,198E,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation D199E shows reduced sensitivity to oseltamivir (16-fold) and zanamivir (7.1-fold).,zanamivir,,low,,N2,199E,N1,
N1,198Y,PMID:32004620,"One virus, with NA D199Y substitution detected in both clinical specimen and virus isolate, exhibited RI by oseltamivir and zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution D199Y exhibits reduced sensitivity to oseltamivir (37-fold), zanamivir (28-fold), peramivir (3.8-fold) and laninamivir (7.1-fold). 
",oseltamivir,,middle,,N2,199Y,N1,
N1,198Y,PMID:32004620,"One virus, with NA D199Y substitution detected in both clinical specimen and virus isolate, exhibited RI by oseltamivir and zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution D199Y exhibits reduced sensitivity to oseltamivir (37-fold), zanamivir (28-fold), peramivir (3.8-fold) and laninamivir (7.1-fold). 
",zanamivir,,middle,,N2,199Y,N1,
N1,198Y,PMID:32004620,"One virus, with NA D199Y substitution detected in both clinical specimen and virus isolate, exhibited RI by oseltamivir and zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution D199Y exhibits reduced sensitivity to oseltamivir (37-fold), zanamivir (28-fold), peramivir (3.8-fold) and laninamivir (7.1-fold). 
",peramivir,,low,,N2,199Y,N1,
N1,198Y,PMID:32004620,"One virus, with NA D199Y substitution detected in both clinical specimen and virus isolate, exhibited RI by oseltamivir and zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution D199Y exhibits reduced sensitivity to oseltamivir (37-fold), zanamivir (28-fold), peramivir (3.8-fold) and laninamivir (7.1-fold). 
",laninamivir,,low,,N2,199Y,N1,
N1,199S,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-N200S reduced sensitivity to oseltamivir (7.1-fold).,oseltamivir,,low,,N2,200S,N1,
N1,222K,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223K shows reduced sensitivity to oseltamivir (23-fold), zanamivir (4.9-fold), peramivir (4.2-fold) and laninamivir (3.6-fold).",oseltamivir,,middle,,N2,223K,N1,
N1,222K,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223K shows reduced sensitivity to oseltamivir (23-fold), zanamivir (4.9-fold), peramivir (4.2-fold) and laninamivir (3.6-fold).",zanamivir,,low,,N2,223K,N1,
N1,222K,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223K shows reduced sensitivity to oseltamivir (23-fold), zanamivir (4.9-fold), peramivir (4.2-fold) and laninamivir (3.6-fold).",peramivir,,low,,N2,223K,N1,
N1,222K,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223K shows reduced sensitivity to oseltamivir (23-fold), zanamivir (4.9-fold), peramivir (4.2-fold) and laninamivir (3.6-fold).",laninamivir,,low,,N2,223K,N1,
N1,222R,PMID:32004620,"A virus with I223R substitution, isolated from an outpatient who had not received NAI treatment, showed RI by oseltamivir and borderline RI by zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution I223R exhibits reduced sensitivity to oseltamivir (14–26-fold) and zanamivir (6.2–11-fold).",oseltamivir,,middle,,N2,223R,N1,
N1,222R,PMID:32004620,"A virus with I223R substitution, isolated from an outpatient who had not received NAI treatment, showed RI by oseltamivir and borderline RI by zanamivir.Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA substitution I223R exhibits reduced sensitivity to oseltamivir (14–26-fold) and zanamivir (6.2–11-fold).",zanamivir,,low,,N2,223R,N1,
N1,222R,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223R shows reduced sensitivity to oseltamivir (13-fold), zanamivir (7.8-fold), peramivir (5.3-fold) and laninamivir (2.3-fold).",oseltamivir,,middle,,N2,223R,N1,
N1,222R,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223R shows reduced sensitivity to oseltamivir (13-fold), zanamivir (7.8-fold), peramivir (5.3-fold) and laninamivir (2.3-fold).",zanamivir,,low,,N2,223R,N1,
N1,222R,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223R shows reduced sensitivity to oseltamivir (13-fold), zanamivir (7.8-fold), peramivir (5.3-fold) and laninamivir (2.3-fold).",peramivir,,low,,N2,223R,N1,
N1,222R,PMID:25721488,"Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223R shows reduced sensitivity to oseltamivir (13-fold), zanamivir (7.8-fold), peramivir (5.3-fold) and laninamivir (2.3-fold).",laninamivir,,low,,N2,223R,N1,
N1,222T,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223T shows reduced sensitivity to oseltamivir (8.9-15-fold) and zanamivir (3.1-3.2-fold).,oseltamivir,,low,,N2,223T,N1,
N1,222T,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation I223T shows reduced sensitivity to oseltamivir (8.9-15-fold) and zanamivir (3.1-3.2-fold).,zanamivir,,low,,N2,223T,N1,
N1,226N,PMID:31168925,"Analysis of the NA protein showed that six Bangladeshi isolates of clade 2.3.2.1a acquired mutations at V96A, I97V, S227N, N275S positions suggesting a reduced susceptibility to antiviral agents such as zanamivir and osteltamivir",oseltamivir,,unknown,,N2,227N,N1,
N1,246G,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation S247G shows reduced sensitivity to oseltamivir (15-fold).,oseltamivir,,middle,,N2,247G,N1,
N1,246N,PMID:33202972,"Analysis of residues involved in IAV resistance to antiviral drugs identified only two H1avN1 strains that each naturally acquired a mutation, assessed to impact the efficacy of NA inhibitors, NA-Y155H classified as highly reduced inhibition (HRI) to oseltamivir and zanamivir, and NA-S247N classified as reduced inhibition (RI) to oseltamivir for H5N1 viruses(WHO).",oseltamivir,,middle,,N2,247N,N1,
N1,246N,PMID:21679678,Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.,oseltamivir,,middle,,N2,247N,N1,
N1,246N,PMID:21679678,Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.,zanamivir,,low,,N2,247N,N1,
N1,246R,PMID:28802866,"Table 1 of the original text mentions that the NA substitution S247R reduced sensitivity to oseltamivir (36-37-fold), zanamivir (51-54-fold), peramivir (94-115-fold) and laninamivir (90-122-fold).",oseltamivir,,middle,,N2,247R,N1,
N1,246R,PMID:28802866,"Table 1 of the original text mentions that the NA substitution S247R reduced sensitivity to oseltamivir (36-37-fold), zanamivir (51-54-fold), peramivir (94-115-fold) and laninamivir (90-122-fold).",zanamivir,,middle,,N2,247R,N1,
N1,246R,PMID:28802866,"Table 1 of the original text mentions that the NA substitution S247R reduced sensitivity to oseltamivir (36-37-fold), zanamivir (51-54-fold), peramivir (94-115-fold) and laninamivir (90-122-fold).",peramivir,,middle,,N2,247R,N1,
N1,246R,PMID:28802866,"Table 1 of the original text mentions that the NA substitution S247R reduced sensitivity to oseltamivir (36-37-fold), zanamivir (51-54-fold), peramivir (94-115-fold) and laninamivir (90-122-fold).",laninamivir,,middle,,N2,247R,N1,
N1,247D,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-N248D reduced sensitivity to oseltamivir (7.1-fold).,oseltamivir,,low,,N2,248D,N1,
N1,263I,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-V264I reduced sensitivity to oseltamivir (7.5-fold).,oseltamivir,,low,,N2,264I,N1,
N1,269K,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-N270K reduced sensitivity to oseltamivir (8.2-fold).,oseltamivir,,low,,N2,270K,N1,
N1,274S,PMID:31168925,"Analysis of the NA protein showed that six Bangladeshi isolates of clade 2.3.2.1a acquired mutations at V96A, I97V, S227N, N275S positions suggesting a reduced susceptibility to antiviral agents such as zanamivir and osteltamivir",oseltamivir,,unknown,,N2,275S,N1,
N1,274Y,PMID:31228489,The CA/04NA−H275Y mutant was highly resistant to oseltamivir(mean IC50 increase: > 950-fold) as compared to the CA/04,oseltamivir,,high,,N2,275Y,N1,
N1,274Y,PMID:31228489,The CA/04NA−H275Y mutant was highly resistant to oseltamivir(mean IC50 increase: > 950-fold) as compared to the CA/04,laninamivir,,low,,N2,275Y,N1,
N1,274Y,PMID:32004620,Viruses with pure H275Y substitution exhibited HRI by oseltamivir (260–2078 fold-increase in IC50) and peramivir (172–495 fold-increase in IC50).,oseltamivir,,high,,N2,275Y,N1,
N1,274Y,PMID:32004620,Viruses with pure H275Y substitution exhibited HRI by oseltamivir (260–2078 fold-increase in IC50) and peramivir (172–495 fold-increase in IC50).,peramivir,,high,,N2,275Y,N1,
N1,274Y,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation H275Y shows reduced sensitivity to oseltamivir (151-2212) and peramivir (87-2045).,oseltamivir,,high,,N2,275Y,N1,
N1,274Y,PMID:25721488,Table 1 of the original text mentions that the virus A(H1N1)pdm09 with NA mutation H275Y shows reduced sensitivity to oseltamivir (151-2212) and peramivir (87-2045).,peramivir,,middle,,N2,275Y,N1,
N1,294S,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",oseltamivir,,middle,,N2,295S,N1,
N1,294S,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",zanamivir,,low,,N2,295S,N1,
N1,294S,PMID:31228489,"Viruses carrying the E119A and N295S mutations were more resistant to oseltamivir (39.4-and 59.5-fold  in mean IC50 value, respectively) and the former was also sig_x005f_x0002_nificantly more resistant to zanamivir and laninamivir(133.5–493.7–fold increase in mean IC50 values) than was the CA/04virus.",laninamivir,,low,,N2,295S,N1,
N1,321V,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-I321V reduced sensitivity to oseltamivir (6.7-fold).,oseltamivir,,low,,N2,321V,N1,
N1,372K,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-N369K reduced sensitivity to oseltamivir (6.6-fold).,oseltamivir,,low,,N2,369K,N1,
N1,390K,PMID:30602610,Table 1 of the original text mentions that the NA mutation rg-N386K reduced sensitivity to oseltamivir (6.4-fold).,oseltamivir,,low,,N2,386K,N1,
N1,399T,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/NCVD-56/2007 with NA change A395T shows reduced sensitivity to oseltamivir (6-fold), zanamivir (3-fold), peramivir (4-fold) and a-315675 (8-fold).",oseltamivir,,low,,N2,395T,N1,
N1,399T,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/NCVD-56/2007 with NA change A395T shows reduced sensitivity to oseltamivir (6-fold), zanamivir (3-fold), peramivir (4-fold) and a-315675 (8-fold).",zanamivir,,low,,N2,395T,N1,
N1,399T,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/NCVD-56/2007 with NA change A395T shows reduced sensitivity to oseltamivir (6-fold), zanamivir (3-fold), peramivir (4-fold) and a-315675 (8-fold).",peramivir,,low,,N2,395T,N1,
N1,406N,PMID:28934457,"Table 3 of the original text mentions that the virus A/chicken/Vietnam/NCVD-086/2008 with NA change D402N shows reduced sensitivity to oseltamivir (4-fold), zanamivir (5-fold), peramivir (4-fold) and a-315675 (11-fold).",oseltamivir,,low,,N2,402N,N1,
N1,406N,PMID:28934457,"Table 3 of the original text mentions that the virus A/chicken/Vietnam/NCVD-086/2008 with NA change D402N shows reduced sensitivity to oseltamivir (4-fold), zanamivir (5-fold), peramivir (4-fold) and a-315675 (11-fold).",zanamivir,,low,,N2,402N,N1,
N1,406N,PMID:28934457,"Table 3 of the original text mentions that the virus A/chicken/Vietnam/NCVD-086/2008 with NA change D402N shows reduced sensitivity to oseltamivir (4-fold), zanamivir (5-fold), peramivir (4-fold) and a-315675 (11-fold).",peramivir,,low,,N2,402N,N1,
N1,424I,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/NCVD-160/2008 with NA change V424I shows reduced sensitivity to oseltamivir (7-fold), zanamivir (3-fold) and a-315675 (8-fold).",oseltamivir,,low,,N2,424I,N1,
N1,424I,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/NCVD-160/2008 with NA change V424I shows reduced sensitivity to oseltamivir (7-fold), zanamivir (3-fold) and a-315675 (8-fold).",zanamivir,,low,,N2,424I,N1,
N1,427T,PMID:32004620,"NA T148A and NA I427T variants showed borderline RI by zanamivir or RI by oseltamivir and zanamivir and borderline RI by laninamivir, respectively.",oseltamivir,,middle,,N2,427T,N1,
N1,427T,PMID:32004620,"NA T148A and NA I427T variants showed borderline RI by zanamivir or RI by oseltamivir and zanamivir and borderline RI by laninamivir, respectively.",zanamivir,,middle,,N2,427T,N1,
N1,427T,PMID:32004620,"NA T148A and NA I427T variants showed borderline RI by zanamivir or RI by oseltamivir and zanamivir and borderline RI by laninamivir, respectively.",laninamivir,,middle,,N2,427T,N1,
N1,432E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-K432E reduced sensitivity to oseltamivir (7.7-fold), zanamivir (2.1-fold), and peramivir (2.3-fold).",oseltamivir,,low,,N2,432E,N1,
N1,432E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-K432E reduced sensitivity to oseltamivir (7.7-fold), zanamivir (2.1-fold), and peramivir (2.3-fold).",zanamivir,,low,,N2,432E,N1,
N1,432E,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-K432E reduced sensitivity to oseltamivir (7.7-fold), zanamivir (2.1-fold), and peramivir (2.3-fold).",peramivir,,low,,N2,432E,N1,
N1,432T,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/Ncvdcdc17/2005 with NA change K432T shows reduced sensitivity to oseltamivir (9-fold), zanamivir (12-fold), peramivir (5-fold) and a-315675 (7-fold).",oseltamivir,,low,,N2,432T,N1,
N1,432T,PMID:28934457,"Table 3 of the original text mentions that the virus A/duck/Vietnam/Ncvdcdc17/2005 with NA change K432T shows reduced sensitivity to oseltamivir (9-fold), zanamivir (12-fold), peramivir (5-fold) and a-315675 (7-fold).",zanamivir,,middle,,N2,432T,N1,
N1,437N,PMID:29493493,"The rg-virus carrying the I436N single substitution exhibited reduced inhibition to all NAIs tested.Table 1 of the original text mentions that the NA mutation rg-I436N reduced sensitivity to oseltamivir (30.8-fold), zanamivir (71.4-fold), peramivir (20.0-fold), and laninamivir (19.7-fold).",oseltamivir,,middle,,N2,436N,N1,
N1,437N,PMID:29493493,"The rg-virus carrying the I436N single substitution exhibited reduced inhibition to all NAIs tested.Table 1 of the original text mentions that the NA mutation rg-I436N reduced sensitivity to oseltamivir (30.8-fold), zanamivir (71.4-fold), peramivir (20.0-fold), and laninamivir (19.7-fold).",zanamivir,,middle,,N2,436N,N1,
N1,437N,PMID:29493493,"The rg-virus carrying the I436N single substitution exhibited reduced inhibition to all NAIs tested.Table 1 of the original text mentions that the NA mutation rg-I436N reduced sensitivity to oseltamivir (30.8-fold), zanamivir (71.4-fold), peramivir (20.0-fold), and laninamivir (19.7-fold).",peramivir,,middle,,N2,436N,N1,
N1,437N,PMID:29493493,"The rg-virus carrying the I436N single substitution exhibited reduced inhibition to all NAIs tested.Table 1 of the original text mentions that the NA mutation rg-I436N reduced sensitivity to oseltamivir (30.8-fold), zanamivir (71.4-fold), peramivir (20.0-fold), and laninamivir (19.7-fold).",laninamivir,,middle,,N2,436N,N1,
N1,459T,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-P458T reduced sensitivity to oseltamivir (280.0-fold), zanamivir (807.8-fold), peramivir (148.0-fold), and laninamivir (210.6-fold).",oseltamivir,,high,,N2,458T,N1,
N1,459T,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-P458T reduced sensitivity to oseltamivir (280.0-fold), zanamivir (807.8-fold), peramivir (148.0-fold), and laninamivir (210.6-fold).",zanamivir,,high,,N2,458T,N1,
N1,459T,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-P458T reduced sensitivity to oseltamivir (280.0-fold), zanamivir (807.8-fold), peramivir (148.0-fold), and laninamivir (210.6-fold).",peramivir,,high,,N2,458T,N1,
N1,459T,PMID:30602610,"Table 1 of the original text mentions that the NA mutation rg-P458T reduced sensitivity to oseltamivir (280.0-fold), zanamivir (807.8-fold), peramivir (148.0-fold), and laninamivir (210.6-fold).",laninamivir,,high,,N2,458T,N1,
N1,96A,PMID:31168925,"Analysis of the NA protein showed that six Bangladeshi isolates of clade 2.3.2.1a acquired mutations at V96A, I97V, S227N, N275S positions suggesting a reduced susceptibility to antiviral agents such as zanamivir and osteltamivir",oseltamivir,,unknown,,N2,96A,N1,
N1,96A,PMID:31168925,"Analysis of the NA protein showed that six Bangladeshi isolates of clade 2.3.2.1a acquired mutations at V96A, I97V, S227N, N275S positions suggesting a reduced susceptibility to antiviral agents such as zanamivir and osteltamivir",zanamivir,,unknown,,N2,96A,N1,
N1,97V,PMID:31168925,"Analysis of the NA protein showed that six Bangladeshi isolates of clade 2.3.2.1a acquired mutations at V96A, I97V, S227N, N275S positions suggesting a reduced susceptibility to antiviral agents such as zanamivir and osteltamivir",oseltamivir,,unknown,,N2,97V,N1,
N8,121V,PMID:34381119,"And in this study, E119V substitution in HPAI H7N9 virus induced a mean 88.03-fold increase in the IC50 of oseltamivir.",oseltamivir,,middle,,N2,119V,N8,
N8,294S,PMID:33933515,"The neuraminidase of 1 strain had an NA-N293/294S (N8/N2 numbering) substitution associated with reduced inhibition by oseltamivir and normal inhibition by zanamivir, which was confirmed phenotypically.",oseltamivir,,low,,N2,293S,N8,
N8,294S,PMID:33933515,"The neuraminidase of 1 strain had an NA-N293/294S (N8/N2 numbering) substitution associated with reduced inhibition by oseltamivir and normal inhibition by zanamivir, which was confirmed phenotypically.",zanamivir,,low,,N2,293S,N8,
M2,26F,PMID:15673732 ,"In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and V27A/S31N mutations in the M2 gene. In plaque reduction assays, all mutations conferred amantadine resistance, with drug concentrations resulting in reduction of plaque number by 50% (IC50s) 154- to 3,300-fold higher than those seen for the wild type (WT).",adamantane,,high,,M2,26F,M2,
M2,26I,PMID:25635767,"Other non-synonymous mutations that were found in amino acid locations known to be associated with drug resistance, namely, I222T in NA gene (sample collected in June 2013; S1 Fig. & Table 1), L26I and V27I (sample collected in May 2010 and May 2012, respectively; S2 Fig. and Table 1) in M2 gene.",adamantane,,unknown,,M2,26I,M2,
M2,27A,PMID:15673732 ,"In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and V27A/S31N mutations in the M2 gene. In plaque reduction assays, all mutations conferred amantadine resistance, with drug concentrations resulting in reduction of plaque number by 50% (IC50s) 154- to 3,300-fold higher than those seen for the wild type (WT).",adamantane,,high,,M2,27A,M2,
M2,27I,PMID:25635767,"Other non-synonymous mutations that were found in amino acid locations known to be associated with drug resistance, namely, I222T in NA gene (sample collected in June 2013; S1 Fig. & Table 1), L26I and V27I (sample collected in May 2010 and May 2012, respectively; S2 Fig. and Table 1) in M2 gene.",adamantane,,unknown,,M2,27I,M2,
M2,27T,PMID:25635767,"Resistance of influenza A/H3N2 to adamantanes is conferred by well-defined mutations, resulting in drug resistant genotypes (DRGs) L26F, V27A, V27T, A30T, A30V, S31N, and S31R in the matrix 2 (M2) gene.",adamantane,,unknown,,M2,27T,M2,
M2,30S,PMID:32454245,"In contrast, the new viruses under study here harbour amino acid substitutions L26F, V27A, A30S, S31N, A30S and G34E in the M2 protein known to enhance resistance to amantadine.",adamantane,,unknown,,M2,30S,M2,
M2,30T,PMID:15673732,"In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and V27A/S31N mutations in the M2 gene. In plaque reduction assays, all mutations conferred amantadine resistance, with drug concentrations resulting in reduction of plaque number by 50% (IC50s) 154- to 3,300-fold higher than those seen for the wild type (WT).",adamantane,,high,,M2,30T,M2,
M2,30V,PMID:25635767,"Resistance of influenza A/H3N2 to adamantanes is conferred by well-defined mutations, resulting in drug resistant genotypes (DRGs) L26F, V27A, V27T, A30T, A30V, S31N, and S31R in the matrix 2 (M2) gene.",adamantane,,unknown,,M2,30V,M2,
M2,31N,PMID:15673732,"In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and V27A/S31N mutations in the M2 gene. In plaque reduction assays, all mutations conferred amantadine resistance, with drug concentrations resulting in reduction of plaque number by 50% (IC50s) 154- to 3,300-fold higher than those seen for the wild type (WT).",adamantane,,high,,M2,31N,M2,
M2,31R,PMID:25635767,"Resistance of influenza A/H3N2 to adamantanes is conferred by well-defined mutations, resulting in drug resistant genotypes (DRGs) L26F, V27A, V27T, A30T, A30V, S31N, and S31R in the matrix 2 (M2) gene.",adamantane,,unknown,,M2,31R,M2,
M2,34E,PMID:15673732,"In this study, reverse genetics was used to generate and characterize recombinant influenza A (H1N1) viruses harboring L26F, V27A, A30T, S31N, G34E, and V27A/S31N mutations in the M2 gene. In plaque reduction assays, all mutations conferred amantadine resistance, with drug concentrations resulting in reduction of plaque number by 50% (IC50s) 154- to 3,300-fold higher than those seen for the wild type (WT).",adamantane,,high,,M2,34E,M2,
N2,116A,PMID:20016036,The NA mutation V116A reduced sensitivity to both oseltamivir (18-fold) and zanamivir (10-fold).,oseltamivir,,high,,N2,116A,N2,
N2,116A,PMID:20016036,The NA mutation V116A reduced sensitivity to both oseltamivir (18-fold) and zanamivir (10-fold).,zanamivir,,low,,N2,116A,N2,
N2,116D,PMID:29046464,"Although virus with the V116D substitution showed slightly decreased susceptibility to OS (4.8-fold IC50 increase) and ZA (7.0-fold IC50 increase) compared to the N8 WT virus, it still had normal inhibition.",oseltamivir,,low,,N2,116D,N2,
N2,116D,PMID:29046464,"Although virus with the V116D substitution showed slightly decreased susceptibility to OS (4.8-fold IC50 increase) and ZA (7.0-fold IC50 increase) compared to the N8 WT virus, it still had normal inhibition.",zanamivir,,low,,N2,116D,N2,
N2,117T,PMID:31282375,"The novel I117T substitution reduced oseltamivir susceptibility by 18.6-fold and zanamivir susceptibility by 11.8-fold, compared to the wild type AI H5N1virus, thus showed cross-resistance to both oseltamivir and zanamivir in NA inhibition assays.",oseltamivir,,middle,,N2,117T,N2,
N2,117T,PMID:31282375,"The novel I117T substitution reduced oseltamivir susceptibility by 18.6-fold and zanamivir susceptibility by 11.8-fold, compared to the wild type AI H5N1virus, thus showed cross-resistance to both oseltamivir and zanamivir in NA inhibition assays.",zanamivir,,middle,,N2,117T,N2,
N2,119A,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119A reduced sensitivity to oseltamivir (7.7-fold), zanamivir (57.9-fold) and peramivir (7.1-fold).",oseltamivir,,low,,N2,119A,N2,
N2,119A,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119A reduced sensitivity to oseltamivir (7.7-fold), zanamivir (57.9-fold) and peramivir (7.1-fold).",zanamivir,,middle,,N2,119A,N2,
N2,119A,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119A reduced sensitivity to oseltamivir (7.7-fold), zanamivir (57.9-fold) and peramivir (7.1-fold).",peramivir,,low,,N2,119A,N2,
N2,119A,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E119A shows reduced sensitivity to oseltamivir (19-fold), zanamivir (228-fold), peramivir (20-fold) and laninamivir (62-fold).",oseltamivir,,middle,,N2,119A,N2,
N2,119A,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E119A shows reduced sensitivity to oseltamivir (19-fold), zanamivir (228-fold), peramivir (20-fold) and laninamivir (62-fold).",zanamivir,,high,,N2,119A,N2,
N2,119A,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E119A shows reduced sensitivity to oseltamivir (19-fold), zanamivir (228-fold), peramivir (20-fold) and laninamivir (62-fold).",peramivir,,middle,,N2,119A,N2,
N2,119A,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E119A shows reduced sensitivity to oseltamivir (19-fold), zanamivir (228-fold), peramivir (20-fold) and laninamivir (62-fold).",laninamivir,,middle,,N2,119A,N2,
N2,119D,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to oseltamivir (22.9-fold), zanamivir (583.4-fold) and peramivir (103.7-fold).",oseltamivir,,middle,,N2,119D,N2,
N2,119D,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to oseltamivir (22.9-fold), zanamivir (583.4-fold) and peramivir (103.7-fold).",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:25320319,"Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to oseltamivir (22.9-fold), zanamivir (583.4-fold) and peramivir (103.7-fold).",peramivir,,high,,N2,119D,N2,
N2,119D,PMID:30910698,The E119D mutation significantly reduced susceptibility to zanamivir (415-fold) and remained susceptible to oseltamivir.,oseltamivir,,low,,N2,119D,N2,
N2,119D,PMID:30910698,The E119D mutation significantly reduced susceptibility to zanamivir (415-fold) and remained susceptible to oseltamivir.,zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:16891631,"In contrast, the rVic/Sydney NA E119D mutant NA showed a 32-fold increase in zanamivir resistance, but only a small increase in resistance to oseltamivir and peramivir.",zanamivir,,middle,,N2,119D,N2,
N2,119D,PMID:18625765,Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to zanamivir (17.0-fold).,zanamivir,,middle,,N2,119D,N2,
N2,119D,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,middle,,N2,119D,N2,
N2,119D,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,high,,N2,119D,N2,
N2,119D,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,119D,N2,
N2,119D,PMID:29046464,"Virus with E119D showed highly reduced inhibition by ZA and reduced inhibition by PER, indicating multi-NAI-resistant markers. Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to zanamivir (248.6-fold) and peramivir (32.4-fold).",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:29046464,"Virus with E119D showed highly reduced inhibition by ZA and reduced inhibition by PER, indicating multi-NAI-resistant markers. Table 1 of the original text mentions that the NA mutation E119D reduced sensitivity to zanamivir (248.6-fold) and peramivir (32.4-fold).",peramivir,,middle,,N2,119D,N2,
N2,119D,PMID:26292325,"Both E119D and E119G conferred either reduced or highly reduced sensitivity to ZA (67.3- and 116-fold, respectively) but did not affect susceptibility to OS and PER. Table 2 of the original text mentions that the NA mutation E119D reduced sensitivity to oseltamivir (3.4-fold).",oseltamivir,,low,,N2,119D,N2,
N2,119D,PMID:26292325,"Both E119D and E119G conferred either reduced or highly reduced sensitivity to ZA (67.3- and 116-fold, respectively) but did not affect susceptibility to OS and PER. Table 2 of the original text mentions that the NA mutation E119D reduced sensitivity to oseltamivir (3.4-fold).",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The E119D substitution, which was selected in the presence of peramivir, significantly increased zanamivir (412-fold), peramivir (222-fold), laninamivir (170-fold) and oseltamivir (4-fold)IC50 values.",oseltamivir,,low,,N2,119D,N2,
N2,119D,PMID:31132385,"The E119D substitution, which was selected in the presence of peramivir, significantly increased zanamivir (412-fold), peramivir (222-fold), laninamivir (170-fold) and oseltamivir (4-fold)IC50 values.",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The E119D substitution, which was selected in the presence of peramivir, significantly increased zanamivir (412-fold), peramivir (222-fold), laninamivir (170-fold) and oseltamivir (4-fold)IC50 values.",peramivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The E119D substitution, which was selected in the presence of peramivir, significantly increased zanamivir (412-fold), peramivir (222-fold), laninamivir (170-fold) and oseltamivir (4-fold)IC50 values.",laninamivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50, and the E119D substitution conferred the greatest changes to zanamivir (752-fold) and peramivir (499-fold) IC50.",oseltamivir,,middle,,N2,119D,N2,
N2,119D,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50, and the E119D substitution conferred the greatest changes to zanamivir (752-fold) and peramivir (499-fold) IC50.",zanamivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50, and the E119D substitution conferred the greatest changes to zanamivir (752-fold) and peramivir (499-fold) IC50.",peramivir,,high,,N2,119D,N2,
N2,119D,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50, and the E119D substitution conferred the greatest changes to zanamivir (752-fold) and peramivir (499-fold) IC50.",laninamivir,,high,,N2,119D,N2,
N2,119G,PMID:19651908,"An E119G neuraminidase mutation, which demonstrated significantly reduced zanamivir susceptibility (1,400-fold compared to the wild type).",zanamivir,,high,,N2,119G,N2,
N2,119G,PMID:31855133,"Two neuraminidase substitutions emerged, H274N (ZA IC50 increased 5.5-fold) and E119G (ZA IC50 increased 110-fold) at 10 and 100 µg l−1 of ZA, respectively.",zanamivir,,high,,N2,119G,N2,
N2,119G,PMID:18625765,Table 1 of the original text mentions that the NA mutation E119G reduced sensitivity to zanamivir (8.0-fold).,zanamivir,,low,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",oseltamivir,,middle,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,high,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,middle,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,119G,N2,
N2,119G,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,119G,N2,
N2,119G,PMID:26292325,"The E119G mutation, which was selected by ZA, reduced inhibition by ZA (523.2-fold), OS (24.5-fold), and PER (13.6-fold) compared to that of the parental N3 virus.",oseltamivir,,middle,,N2,119G,N2,
N2,119G,PMID:26292325,"The E119G mutation, which was selected by ZA, reduced inhibition by ZA (523.2-fold), OS (24.5-fold), and PER (13.6-fold) compared to that of the parental N3 virus.",zanamivir,,high,,N2,119G,N2,
N2,119G,PMID:26292325,"The E119G mutation, which was selected by ZA, reduced inhibition by ZA (523.2-fold), OS (24.5-fold), and PER (13.6-fold) compared to that of the parental N3 virus.",peramivir,,middle,,N2,119G,N2,
N2,119G,PMID:26292325,"Both E119D and E119G conferred either reduced or highly reduced sensitivity to ZA (67.3- and 100.6-fold, respectively) but did not affect susceptibility to OS and PER.",zanamivir,,middle,,N2,119G,N2,
N2,119I,PMID: 20194700,"For example, in the fluorescent assay, the confirmed oseltamivir resistance of the E119V and E119I variants was based on 558- and 979-fold increases in IC50s, respectively, compared to 34- and 208-fold increases, respectively, in the chemiluminescent assay.Table 1 and table 2 of the original text mentions that the  NA mutations 119I shows reduced sensitivity to peramivir(3-428.0-fold) and zanamivir (12-17-fold).",oseltamivir,,high,,N2,119I,N2,
N2,119I,PMID: 20194700,"For example, in the fluorescent assay, the confirmed oseltamivir resistance of the E119V and E119I variants was based on 558- and 979-fold increases in IC50s, respectively, compared to 34- and 208-fold increases, respectively, in the chemiluminescent assay.Table 1 and table 2 of the original text mentions that the  NA mutations 119I shows reduced sensitivity to peramivir(3-428.0-fold) and zanamivir (12-17-fold).",zanamivir,,middle,,N2,119I,N2,
N2,119I,PMID: 20194700,"For example, in the fluorescent assay, the confirmed oseltamivir resistance of the E119V and E119I variants was based on 558- and 979-fold increases in IC50s, respectively, compared to 34- and 208-fold increases, respectively, in the chemiluminescent assay.Table 1 and table 2 of the original text mentions that the  NA mutations 119I shows reduced sensitivity to peramivir(3-428.0-fold) and zanamivir (12-17-fold).",peramivir,,low,,N2,119I,N2,
N2,119V,PMID:21148493,"Table 1 of the original text mentions that the NA mutation E119V reduced sensitivity to oseltamivir (60.2-fold), zanamivir (571.0-fold) and peramivir (25.3-fold).",oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:21148493,"Table 1 of the original text mentions that the NA mutation E119V reduced sensitivity to oseltamivir (60.2-fold), zanamivir (571.0-fold) and peramivir (25.3-fold).",zanamivir,,high,,N2,119V,N2,
N2,119V,PMID:21148493,"Table 1 of the original text mentions that the NA mutation E119V reduced sensitivity to oseltamivir (60.2-fold), zanamivir (571.0-fold) and peramivir (25.3-fold).",peramivir,,middle,,N2,119V,N2,
N2,119V,PMID:32004620,One virus with NA E119V substitution showed HRI by oseltamivir but had no effect on susceptibility to the other NAIs.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution E119V exhibits reduced sensitivity to oseltamivir (212-fold) and zanamivir (2.3-fold).,oseltamivir,,high,,N2,119V,N2,
N2,119V,PMID:32004620,One virus with NA E119V substitution showed HRI by oseltamivir but had no effect on susceptibility to the other NAIs.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution E119V exhibits reduced sensitivity to oseltamivir (212-fold) and zanamivir (2.3-fold).,zanamivir,,low,,N2,119V,N2,
N2,119V,PMID:33322333,"When assessed in NA inhibition assays, these E119V variants had mean IC50 values of 81.00 ± 0.01 nM and 80.39 ± 0.12 nM, respectively, equivalent to 192.9 and 191.4-fold increases compared to the A/H3N2-WT IC50",oseltamivir,,high,,N2,119V,N2,
N2,119V,PMID:32750468,The OSE IC50 values for the E119V mutation in all three viruses demonstrated RI.The results of MUNANA assay with ZAN showed that E119V mutation conferred HRI only in H5N8 virus.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:32750468,The OSE IC50 values for the E119V mutation in all three viruses demonstrated RI.The results of MUNANA assay with ZAN showed that E119V mutation conferred HRI only in H5N8 virus.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,zanamivir,,high,,N2,119V,N2,
N2,119V,PMID:32750468,The OSE IC50 values for the E119V mutation in all three viruses demonstrated RI.The results of MUNANA assay with ZAN showed that E119V mutation conferred HRI only in H5N8 virus.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,peramivir,,high,,N2,119V,N2,
N2,119V,PMID:24215378,"In the N2 subtype, the most frequent mutations conferring highly reduced inhibition to oseltamivir are E119V and R292K, the latter being also associated with reduced inhibition to zanamivir",oseltamivir,,high,,N2,119V,N2,
N2,119V,PMID:21422222,"The E119V+I222L mutant was found to be 1,571 times more resistant to oseltamivir than the wild type was, whereas the E119V mutation induced a moderate resistance (197-fold) and the I222L mutation induced a slight resistance (9-fold).",oseltamivir,,high,,N2,119V,N2,
N2,119V,PMID:33055248,Viruses with E119V or L91I-E119V substitutions in the N5 subtype exhibited HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.,oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:33055248,Viruses with E119V or L91I-E119V substitutions in the N5 subtype exhibited HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.,zanamivir,,high,,N2,119V,N2,
N2,119V,PMID:33055248,Viruses with E119V or L91I-E119V substitutions in the N5 subtype exhibited HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.,peramivir,,middle,,N2,119V,N2,
N2,119V,PMID:33055248,Viruses with E119V or L91I-E119V substitutions in the N5 subtype exhibited HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.,laninamivir,,high,,N2,119V,N2,
N2,119V,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:27432605,"Viruses bearing E119V variant N3 or N6 showed NI by oseltamivir, whereas viruses with E119V variant N7 or N9 showed RI by oseltamivir (48- and 29-fold increase in IC50, respectively) and viruses with E119V variant N2 showed HRI by oseltamivir (296-fold increase in IC50).",oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:27432605,"Viruses bearing E119V variant N3 or N6 showed NI by oseltamivir, whereas viruses with E119V variant N7 or N9 showed RI by oseltamivir (48- and 29-fold increase in IC50, respectively) and viruses with E119V variant N2 showed HRI by oseltamivir (296-fold increase in IC50).",oseltamivir,,high,,N2,119V,N2,
N2,119V,PMID:29046464,"Of note, virus with the single E119V substitution showed reduced inhibition by OS (58.5-fold IC50 increase) and PER (63.9-fold IC50 increase) and highly reduced inhibition by ZA (736.6-fold IC50 increase) compared to that of the N5 WT virus.",oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:29046464,"Of note, virus with the single E119V substitution showed reduced inhibition by OS (58.5-fold IC50 increase) and PER (63.9-fold IC50 increase) and highly reduced inhibition by ZA (736.6-fold IC50 increase) compared to that of the N5 WT virus.",zanamivir,,high,,N2,119V,N2,
N2,119V,PMID:29046464,"Of note, virus with the single E119V substitution showed reduced inhibition by OS (58.5-fold IC50 increase) and PER (63.9-fold IC50 increase) and highly reduced inhibition by ZA (736.6-fold IC50 increase) compared to that of the N5 WT virus.",peramivir,,middle,,N2,119V,N2,
N2,119V,PMID:26292325,Viruses with the E119V mutation were associated with reduced inhibition by OS (55.3-fold increase) but remained susceptible to ZA and PER.,oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:26292325,Table 3 of the original text mentions that the NA mutation E119V reduced sensitivity to oseltamivir (49.5-fold) and zanamivir (3.0-fold).,oseltamivir,,middle,,N2,119V,N2,
N2,119V,PMID:26292325,Table 3 of the original text mentions that the NA mutation E119V reduced sensitivity to oseltamivir (49.5-fold) and zanamivir (3.0-fold).,zanamivir,,low,,N2,119V,N2,
N2,119V,PMID:34381119,"In this study, the two mutations of E119V-I222L were chosen to study the synergistic drug resistance of HPAI H7N9 virus in mice. The IC50 fold change of oseltamivir to rg006NA222L-119V is 306.34 times than that of its susceptible strain, and 3.5 times than that of the E119V single point mutant virus, which showed synergistic resistance effect.",oseltamivir,,low,,N2,119V,N2,
N2,132I,PMID:29046464,Table 1 of the original text mentions that the NA mutation F132I reduced sensitivity to peramivir (2.2-fold) and zanamivir (3.4-fold).,zanamivir,,low,,N2,132I,N2,
N2,132I,PMID:29046464,Table 1 of the original text mentions that the NA mutation F132I reduced sensitivity to peramivir (2.2-fold) and zanamivir (3.4-fold).,peramivir,,low,,N2,132I,N2,
N2,136K,PMID:19641000,"Analysis of 391 influenza A (H1N1) viruses isolated between 2006 and early 2008 from Australasia and Southeast Asia revealed nine viruses (2.3%) that demonstrated markedly reduced zanamivir susceptibility and contained a previously undescribed Gln136Lys (Q136K) neuraminidase mutation. The mutation had no effect on oseltamivir susceptibility but caused approximately a 300-fold and a 70-fold reduction in zanamivir and peramivir susceptibility, respectively.",zanamivir,,high,,N2,136K,N2,
N2,136K,PMID:19641000,"Analysis of 391 influenza A (H1N1) viruses isolated between 2006 and early 2008 from Australasia and Southeast Asia revealed nine viruses (2.3%) that demonstrated markedly reduced zanamivir susceptibility and contained a previously undescribed Gln136Lys (Q136K) neuraminidase mutation. The mutation had no effect on oseltamivir susceptibility but caused approximately a 300-fold and a 70-fold reduction in zanamivir and peramivir susceptibility, respectively.",peramivir,,middle,,N2,136K,N2,
N2,136K,PMID:19917319,Table 3 of the original text mentions that the NA mutation Q136K reduced sensitivity to zanamivir (36.0-fold) and peramivir (80.0-fold).,zanamivir,,middle,,N2,136K,N2,
N2,136K,PMID:19917319,Table 3 of the original text mentions that the NA mutation Q136K reduced sensitivity to zanamivir (36.0-fold) and peramivir (80.0-fold).,peramivir,,middle,,N2,136K,N2,
N2,136K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,high,,N2,136K,N2,
N2,136K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Please refer to Table 1 of the original article for the specific fold change values.",peramivir,,high,,N2,136K,N2,
N2,136K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,high,,N2,136K,N2,
N2,136K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,high,,N2,136K,N2,
N2,136K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,middle,,N2,136K,N2,
N2,136K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,136K,N2,
N2,136K,PMID:28458567,Table 1 of the original text mentions that the NA mutation Q136K in subtype H3N2 shows reduced sensitivity to zanamivir (11-fold) and peramivir (2.5-9.0-fold).,zanamivir,,middle,,N2,136K,N2,
N2,136K,PMID:28458567,Table 1 of the original text mentions that the NA mutation Q136K in subtype H3N2 shows reduced sensitivity to zanamivir (11-fold) and peramivir (2.5-9.0-fold).,peramivir,,low,,N2,136K,N2,
N2,136K,PMID:29046464,The Q136K substitution demonstrated highly reduced inhibition by ZA (263.4-fold IC50 increase) and PER (184.9-fold IC50 increase).,zanamivir,,high,,N2,136K,N2,
N2,136K,PMID:29046464,The Q136K substitution demonstrated highly reduced inhibition by ZA (263.4-fold IC50 increase) and PER (184.9-fold IC50 increase).,peramivir,,high,,N2,136K,N2,
N2,136K,PMID:26292325,Q136K was associated with highly reduced inhibition to ZA (121.1-fold) and reduced inhibition to PER (53.9-fold).,zanamivir,,high,,N2,136K,N2,
N2,136K,PMID:26292325,Q136K was associated with highly reduced inhibition to ZA (121.1-fold) and reduced inhibition to PER (53.9-fold).,peramivir,,middle,,N2,136K,N2,
N2,142S,PMID:28458567,Table 1 of the original text mentions that the NA mutation N142S in subtype H3N2 reduced sensitivity to oseltamivir (595.0-fold) and zanamivir (244.0-fold) and peramivir (40.0-fold).,oseltamivir,,high,,N2,142S,N2,
N2,142S,PMID:28458567,Table 1 of the original text mentions that the NA mutation N142S in subtype H3N2 reduced sensitivity to oseltamivir (595.0-fold) and zanamivir (244.0-fold) and peramivir (40.0-fold).,zanamivir,,high,,N2,142S,N2,
N2,142S,PMID:28458567,Table 1 of the original text mentions that the NA mutation N142S in subtype H3N2 reduced sensitivity to oseltamivir (595.0-fold) and zanamivir (244.0-fold) and peramivir (40.0-fold).,peramivir,,middle,,N2,142S,N2,
N2,147I,PMID:33055248,Please refer to Table 1 of the original article for the specific fold change values.,zanamivir,,middle,,N2,147I,N2,
N2,147I,PMID:29046464,The single N147I substitution selected by ZA showed reduced inhibition by the drug (30.7-fold IC50 increase). Table 1 of the original text mentions that the NA mutation N147I reduced sensitivity to zanamivir (30.7-fold) and peramivir (3.3-fold).,zanamivir,,middle,,N2,147I,N2,
N2,147V,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,middle,,N2,147V,N2,
N2,147V,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,middle,,N2,147V,N2,
N2,147V,PMID:29046464,The novel G147V substitution showed reduced inhibition by ZA (24.9-fold IC50 increase) compared to the N8 WT virus. Table 1 of the original text mentions that the NA mutation G147V reduced sensitivity to zanamivir (24.9-fold)and peramivir (4.9-fold).,zanamivir,,middle,,N2,147V,N2,
N2,147V,PMID:29046464,The novel G147V substitution showed reduced inhibition by ZA (24.9-fold IC50 increase) compared to the N8 WT virus. Table 1 of the original text mentions that the NA mutation G147V reduced sensitivity to zanamivir (24.9-fold)and peramivir (4.9-fold).,peramivir,,low,,N2,147V,N2,
N2,148I,PMID:24080660,"Using recombinant proteins, T148I by itself was shown to cause only a 6-fold increase in the zanamivir 50% inhibitory concentration (IC50) and had no effect on inhibition by other drugs.",oseltamivir,,low,,N2,148I,N2,
N2,148K,PMID:25721488,Table 1 of the original text mentions that the virus A(H3N2) with NA mutation T148K shows reduced sensitivity to zanamivir (10-fold).,oseltamivir,,low,,N2,148K,N2,
N2,151A,PMID:24215378,Table 1 of the original text indicates that the NA mutation D151A/D in subtype A(H3N2) confers susceptibility or normal inhibition (<10-fold increase in IC50 over WT) to oseltamivir and highly reduced inhibition (>100-fold increase in IC50 over WT) to zanamivir.,zanamivir,,high,,N2,151A,N2,
N2,151D,PMID:24215378,Table 1 of the original text indicates that the NA mutation D151A/D in subtype A(H3N2) confers susceptibility or normal inhibition (<10-fold increase in IC50 over WT) to oseltamivir and highly reduced inhibition (>100-fold increase in IC50 over WT) to zanamivir.,zanamivir,,high,,N2,151D,N2,
N2,151E,PMID:16912325,The D151E virus conferred resistance to both oseltamivir carboxylate (>10-fold)(Table 6).,oseltamivir,,middle,,N2,151E,N2,
N2,151G,PMID:24239666,"The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses.By itself, the recombinant G151 protein shows >1000-fold elevated zanamivir-IC50 in both assays.",zanamivir,,high,,N2,151G,N2,
N2,152K,PMID:25320319,"Table 1 of the original text mentions that the NA mutation R152K reduced sensitivity to oseltamivir (17.9-fold) , zanamivir (4.4-fold) and peramivir(3.7-fold).",oseltamivir,,middle,,N2,152K,N2,
N2,152K,PMID:25320319,"Table 1 of the original text mentions that the NA mutation R152K reduced sensitivity to oseltamivir (17.9-fold) , zanamivir (4.4-fold) and peramivir(3.7-fold).",zanamivir,,low,,N2,152K,N2,
N2,152K,PMID:25320319,"Table 1 of the original text mentions that the NA mutation R152K reduced sensitivity to oseltamivir (17.9-fold) , zanamivir (4.4-fold) and peramivir(3.7-fold).",peramivir,,low,,N2,152K,N2,
N2,152K,PMID:31132385,"The R152K substitution, selected by passage in both peramivir and laninamivir, was associated with a 22-fold increase in laninamivir IC50 and 5-fold increase in zanamivir IC50, which was significant. The R152K substitutions also increased peramivir IC50 by 8-fold, but this was not significant.",zanamivir,,low,,N2,152K,N2,
N2,152K,PMID:31132385,"The R152K substitution, selected by passage in both peramivir and laninamivir, was associated with a 22-fold increase in laninamivir IC50 and 5-fold increase in zanamivir IC50, which was significant. The R152K substitutions also increased peramivir IC50 by 8-fold, but this was not significant.",peramivir,,low,,N2,152K,N2,
N2,152K,PMID:31132385,"The R152K substitution, selected by passage in both peramivir and laninamivir, was associated with a 22-fold increase in laninamivir IC50 and 5-fold increase in zanamivir IC50, which was significant. The R152K substitutions also increased peramivir IC50 by 8-fold, but this was not significant.",laninamivir,,middle,,N2,152K,N2,
N2,152K,PMID:31132385,"Similarly, the R152K substitution lead to significant increases in zanamivir (8-fold) and laninamivir (32-fold) IC50s. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,low,,N2,152K,N2,
N2,152K,PMID:31132385,"Similarly, the R152K substitution lead to significant increases in zanamivir (8-fold) and laninamivir (32-fold) IC50s. Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,middle,,N2,152K,N2,
N2,152K,PMID:31132385,"Similarly, the R152K substitution lead to significant increases in zanamivir (8-fold) and laninamivir (32-fold) IC50s. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,low,,N2,152K,N2,
N2,152K,PMID:16891631,"The N9 R152K NA demonstrated a slightly higher level of resistance to zanamivir (9.6×) than to oseltamivir compared with the N2 NA, although still much lower than seen in the B NA.Table 4 of the original text mentions that the NA mutation R152K reduced sensitivity to zanamivir (9.6-fold) and peramivir (12-fold).",zanamivir,,low,,N2,152K,N2,
N2,152K,PMID:16891631,"The N9 R152K NA demonstrated a slightly higher level of resistance to zanamivir (9.6×) than to oseltamivir compared with the N2 NA, although still much lower than seen in the B NA.Table 4 of the original text mentions that the NA mutation R152K reduced sensitivity to zanamivir (9.6-fold) and peramivir (12-fold).",peramivir,,middle,,N2,152K,N2,
N2,152W,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,middle,,N2,152W,N2,
N2,152W,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,middle,,N2,152W,N2,
N2,152W,PMID:26292325,"An Arg (R)-to-Trp (W) substitution at position 152 is a novel NA mutation that conferred reduced NAI susceptibility, and the mutation is associated with resistance to both OS (14.1-fold) and ZA (11.4-fold), with susceptibility to PER unaltered.",oseltamivir,,middle,,N2,152W,N2,
N2,152W,PMID:26292325,"An Arg (R)-to-Trp (W) substitution at position 152 is a novel NA mutation that conferred reduced NAI susceptibility, and the mutation is associated with resistance to both OS (14.1-fold) and ZA (11.4-fold), with susceptibility to PER unaltered.",zanamivir,,middle,,N2,152W,N2,
N2,155H,PMID:16801417,Table 4 of the original text mentions that the NA mutation Y155H reduced sensitivity to oseltamivir (123-fold) and zanamivir (555-fold).,oseltamivir,,high,,N2,155H,N2,
N2,155H,PMID:16801417,Table 4 of the original text mentions that the NA mutation Y155H reduced sensitivity to oseltamivir (123-fold) and zanamivir (555-fold).,zanamivir,,high,,N2,155H,N2,
N2,161N,PMID:32004620,Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D161N exhibits reduced sensitivity to oseltamivir (9.1-fold) and zanamivir (10.5-fold).,oseltamivir,,low,,N2,161N,N2,
N2,161N,PMID:32004620,Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D161N exhibits reduced sensitivity to oseltamivir (9.1-fold) and zanamivir (10.5-fold).,zanamivir,,middle,,N2,161N,N2,
N2,198E,PMID:28458567,Table 1 of the original text mentions that the NA mutation D198E reduced sensitivity to oseltamivir (16.0-fold) and zanamivir (7.1-fold).,oseltamivir,,middle,,N2,198E,N2,
N2,198E,PMID:28458567,Table 1 of the original text mentions that the NA mutation D198E reduced sensitivity to oseltamivir (16.0-fold) and zanamivir (7.1-fold).,zanamivir,,low,,N2,198E,N2,
N2,198G,PMID:21148493,"Table 1 of the original text mentions that the NA mutation D198G reduced sensitivity to oseltamivir (16.8-fold), zanamivir (6.0-fold) and peramivir (2.4-fold).",oseltamivir,,middle,,N2,198G,N2,
N2,198G,PMID:21148493,"Table 1 of the original text mentions that the NA mutation D198G reduced sensitivity to oseltamivir (16.8-fold), zanamivir (6.0-fold) and peramivir (2.4-fold).",zanamivir,,low,,N2,198G,N2,
N2,198G,PMID:21148493,"Table 1 of the original text mentions that the NA mutation D198G reduced sensitivity to oseltamivir (16.8-fold), zanamivir (6.0-fold) and peramivir (2.4-fold).",peramivir,,low,,N2,198G,N2,
N2,198G,PMID:21148493,"Table 1 of the original text mentions that the NA mutation D198G reduced sensitivity to oseltamivir (16.8-fold), zanamivir (6.0-fold) and peramivir (2.4-fold).",laninamivir,,low,,N2,198G,N2,
N2,198G,PMID:19651908,"The D198G mutation identified in the Vn/1203 strain following zanamivir passage resulted in 44-fold, 32-fold, and 4-fold increases in the IC50s for zanamivir, oseltamivir, and peramivir, respectively, in the recombinant strains.",oseltamivir,,middle,,N2,198G,N2,
N2,198G,PMID:19651908,"The D198G mutation identified in the Vn/1203 strain following zanamivir passage resulted in 44-fold, 32-fold, and 4-fold increases in the IC50s for zanamivir, oseltamivir, and peramivir, respectively, in the recombinant strains.",zanamivir,,middle,,N2,198G,N2,
N2,198G,PMID:19651908,"The D198G mutation identified in the Vn/1203 strain following zanamivir passage resulted in 44-fold, 32-fold, and 4-fold increases in the IC50s for zanamivir, oseltamivir, and peramivir, respectively, in the recombinant strains.",peramivir,,low,,N2,198G,N2,
N2,198N,PMID:25320319,"Table 1 of the original text mentions that the NA mutation D198N reduced sensitivity to oseltamivir (4.2-fold), zanamivir (4.1-fold) and peramivir (3.0-fold).",oseltamivir,,low,,N2,198N,N2,
N2,198N,PMID:25320319,"Table 1 of the original text mentions that the NA mutation D198N reduced sensitivity to oseltamivir (4.2-fold), zanamivir (4.1-fold) and peramivir (3.0-fold).",zanamivir,,low,,N2,198N,N2,
N2,198N,PMID:25320319,"Table 1 of the original text mentions that the NA mutation D198N reduced sensitivity to oseltamivir (4.2-fold), zanamivir (4.1-fold) and peramivir (3.0-fold).",peramivir,,low,,N2,198N,N2,
N2,221H,PMID:29046464,Table 1 of the original text mentions that the NA mutation Q221H reduced sensitivity to zanamivir (2.7-fold).,zanamivir,,low,,N2,221H,N2,
N2,222K,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,high,,N2,222K,N2,
N2,222K,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,low,,N2,222K,N2,
N2,222K,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,low,,N2,222K,N2,
N2,222K,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,laninamivir,,low,,N2,222K,N2,
N2,222K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",oseltamivir,,middle,,N2,222K,N2,
N2,222K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",zanamivir,,middle,,N2,222K,N2,
N2,222K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",peramivir,,middle,,N2,222K,N2,
N2,222K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",laninamivir,,middle,,N2,222K,N2,
N2,222L,PMID:21422222,"The E119V+I222L mutant was found to be 1,571 times more resistant to oseltamivir than the wild type was, whereas the E119V mutation induced a moderate resistance (197-fold) and the I222L mutation induced a slight resistance (9-fold).",oseltamivir,,low,,N2,222L,N2,
N2,222M,PMID:19651908,"Single I222M and H274Y mutations in the Laos/26 NA resulted in 36- and 911-fold increases in the oseltamivir IC50, respectively, but together caused a >8,000-fold increase (Table 3).",oseltamivir,,middle,,N2,222M,N2,
N2,222M,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,middle,,N2,222M,N2,
N2,222M,PMID:26292325,"Table 3 of the original text mentions that the NA mutation I222M reduced sensitivity to oseltamivir (18.3-fold), zanamivir (4.0-fold), and peramivir (4.0-fold).",oseltamivir,,middle,,N2,222M,N2,
N2,222M,PMID:26292325,"Table 3 of the original text mentions that the NA mutation I222M reduced sensitivity to oseltamivir (18.3-fold), zanamivir (4.0-fold), and peramivir (4.0-fold).",zanamivir,,low,,N2,222M,N2,
N2,222M,PMID:26292325,"Table 3 of the original text mentions that the NA mutation I222M reduced sensitivity to oseltamivir (18.3-fold), zanamivir (4.0-fold), and peramivir (4.0-fold).",peramivir,,low,,N2,222M,N2,
N2,222R,PMID:28458567,"Table 1 of the original text mentions that the NA mutation I222R in subtype pH1N1 shows reduced sensitivity to oseltamivir (13.0-58-fold) , zanamivir (7.0-10.0fold) ,peramivir (5.3-10.0-fold) and laninamivir (2.2-2.3-fold).",oseltamivir,,middle,,N2,222R,N2,
N2,222R,PMID:28458567,"Table 1 of the original text mentions that the NA mutation I222R in subtype pH1N1 shows reduced sensitivity to oseltamivir (13.0-58-fold) , zanamivir (7.0-10.0fold) ,peramivir (5.3-10.0-fold) and laninamivir (2.2-2.3-fold).",zanamivir,,low,,N2,222R,N2,
N2,222R,PMID:28458567,"Table 1 of the original text mentions that the NA mutation I222R in subtype pH1N1 shows reduced sensitivity to oseltamivir (13.0-58-fold) , zanamivir (7.0-10.0fold) ,peramivir (5.3-10.0-fold) and laninamivir (2.2-2.3-fold).",peramivir,,low,,N2,222R,N2,
N2,222R,PMID:28458567,"Table 1 of the original text mentions that the NA mutation I222R in subtype pH1N1 shows reduced sensitivity to oseltamivir (13.0-58-fold) , zanamivir (7.0-10.0fold) ,peramivir (5.3-10.0-fold) and laninamivir (2.2-2.3-fold).",laninamivir,,low,,N2,222R,N2,
N2,222R,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,high,,N2,222R,N2,
N2,222R,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,low,,N2,222R,N2,
N2,222R,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,high,,N2,222R,N2,
N2,222R,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,laninamivir,,high,,N2,222R,N2,
N2,222R,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation I222R shows reduced sensitivity to oseltamivir (143-fold), zanamivir (38-fold), peramivir (44-fold) and laninamivir (63-fold).",oseltamivir,,high,,N2,222R,N2,
N2,222R,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation I222R shows reduced sensitivity to oseltamivir (143-fold), zanamivir (38-fold), peramivir (44-fold) and laninamivir (63-fold).",zanamivir,,middle,,N2,222R,N2,
N2,222R,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation I222R shows reduced sensitivity to oseltamivir (143-fold), zanamivir (38-fold), peramivir (44-fold) and laninamivir (63-fold).",peramivir,,middle,,N2,222R,N2,
N2,222R,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation I222R shows reduced sensitivity to oseltamivir (143-fold), zanamivir (38-fold), peramivir (44-fold) and laninamivir (63-fold).",laninamivir,,middle,,N2,222R,N2,
N2,222T,PMID:25635767,The I222T mutation of NA gene detected in this study has been recently reported to cause decreased oseltamivir susceptibility (with a 16-fold increase in IC50 compared to that of the wild-type) in influenza A/H3N2.,oseltamivir,,middle,,N2,222T,N2,
N2,222T,PMID:25635767,The I222T mutation of NA gene detected in this study has been recently reported to cause decreased oseltamivir susceptibility (with a 16-fold increase in IC50 compared to that of the wild-type) in influenza A/H3N2.,zanamivir,,unknown,,N2,222T,N2,
N2,222V,PMID:19651908,Table 3 of the original text mentions that the recombinant virus Laos/26 H5N1 I222V shows reduced sensitivity to oseltamivir (7-fold).,oseltamivir,,low,,N2,222V,N2,
N2,222V,PMID:31356626,Analysis of the NA of all studied A(H3N2) viruses for the presence of mutations conferring drug resistance revealed I222V amino acid substitution in the NA of A/Astrakhan/32/2017 strain. An association of this mutation with a slight increase in oseltamivir IC50 (less than 10 times) was shown for A(H1N1).,oseltamivir,,low,,N2,222V,N2,
N2,222V,PMID:21148493,Table 1 of the original text mentions that the NA mutation I222V reduced sensitivity to oseltamivir (5.7-fold) and zanamivir (2.3-fold).,oseltamivir,,low,,N2,222V,N2,
N2,222V,PMID:21148493,Table 1 of the original text mentions that the NA mutation I222V reduced sensitivity to oseltamivir (5.7-fold) and zanamivir (2.3-fold).,zanamivir,,low,,N2,222V,N2,
N2,224K,PMID:16912325,The R224K virus conferred resistance to both oseltamivir carboxylate (>1000-fold) and zanamivir (>10-fold) (Table 5).,oseltamivir,,high,,N2,224K,N2,
N2,224K,PMID:16912325,The R224K virus conferred resistance to both oseltamivir carboxylate (>1000-fold) and zanamivir (>10-fold) (Table 5).,zanamivir,,middle,,N2,224K,N2,
N2,226H,PMID:16801417,Table 4 of the original text mentions that the NA mutation Q226H reduced sensitivity to oseltamivir (13.5-fold).,oseltamivir,,middle,,N2,226H,N2,
N2,246F,PMID:29046464,Table 1 of the original text mentions that the NA mutation S246F reduced sensitivity to zanamivir (3.8-fold).,zanamivir,,low,,N2,246F,N2,
N2,246N,PMID:20016036,"A unique, previously unreported mutation, S246N, identified in two isolates, reduced the sensitivity of isolate A/chicken/Laos/13/08 to oseltamivir by 24-fold as a single mutation.",oseltamivir,,high,,N2,246N,N2,
N2,246T,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,middle,,N2,246T,N2,
N2,246T,PMID:26292325,"A246T, a novel NAI resistance mutation, reduced sensitivity to ZA (25.4-fold) but did not affect inhibition by OS (6.2-fold) and PER (7.2-fold).",oseltamivir,,low,,N2,246T,N2,
N2,246T,PMID:26292325,"A246T, a novel NAI resistance mutation, reduced sensitivity to ZA (25.4-fold) but did not affect inhibition by OS (6.2-fold) and PER (7.2-fold).",zanamivir,,middle,,N2,246T,N2,
N2,246T,PMID:26292325,"A246T, a novel NAI resistance mutation, reduced sensitivity to ZA (25.4-fold) but did not affect inhibition by OS (6.2-fold) and PER (7.2-fold).",peramivir,,low,,N2,246T,N2,
N2,246V,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,246V,N2,
N2,246V,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,246V,N2,
N2,246V,PMID:29046464,"The novel A246V substitution (selected by ZA) showed reduced inhibition by ZA (17.0-fold IC50 increase). Table 1 of the original text mentions that the NA mutation A246V reduced sensitivity to oseltamivir (2.8-fold), zanamivir (17.0-fold), and peramivir (5.4-fold).",oseltamivir,,low,,N2,246V,N2,
N2,246V,PMID:29046464,"The novel A246V substitution (selected by ZA) showed reduced inhibition by ZA (17.0-fold IC50 increase). Table 1 of the original text mentions that the NA mutation A246V reduced sensitivity to oseltamivir (2.8-fold), zanamivir (17.0-fold), and peramivir (5.4-fold).",zanamivir,,middle,,N2,246V,N2,
N2,246V,PMID:29046464,"The novel A246V substitution (selected by ZA) showed reduced inhibition by ZA (17.0-fold IC50 increase). Table 1 of the original text mentions that the NA mutation A246V reduced sensitivity to oseltamivir (2.8-fold), zanamivir (17.0-fold), and peramivir (5.4-fold).",peramivir,,low,,N2,246V,N2,
N2,247P,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation T247P shows reduced sensitivity to oseltamivir (27-fold), zanamivir (69-fold), peramivir (4-fold) and laninamivir (9-fold).",oseltamivir,,middle,,N2,247P,N2,
N2,247P,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation T247P shows reduced sensitivity to oseltamivir (27-fold), zanamivir (69-fold), peramivir (4-fold) and laninamivir (9-fold).",zanamivir,,middle,,N2,247P,N2,
N2,247P,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation T247P shows reduced sensitivity to oseltamivir (27-fold), zanamivir (69-fold), peramivir (4-fold) and laninamivir (9-fold).",peramivir,,low,,N2,247P,N2,
N2,247P,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation T247P shows reduced sensitivity to oseltamivir (27-fold), zanamivir (69-fold), peramivir (4-fold) and laninamivir (9-fold).",laninamivir,,low,,N2,247P,N2,
N2,249E,PMID:28802866,"All viruses harboured NA K249E AAS, which has previously been seen in viruses displaying a borderline RI by oseltamivir.",oseltamivir,,middle,,N2,249E,N2,
N2,274N,PMID:31855133,"Two neuraminidase substitutions emerged, H274N (ZA IC50 increased 5.5-fold) and E119G (ZA IC50 increased 110-fold) at 10 and 100 µg l−1 of ZA, respectively.",zanamivir,,low,,N2,274N,N2,
N2,274Y,PMID:19651908,"The H274Y neuraminidase mutation reduced oseltamivir susceptibility significantly (900- to 2,500-fold compared to the wild type).",oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,middle,,N2,274Y,N2,
N2,274Y,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,N2,274Y,N2,
N2,274Y,PMID:33055248,Please refer to Table 1 of the original article for the specific fold change values.,oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:33055248,Please refer to Table 1 of the original article for the specific fold change values.,peramivir,,high,,N2,274Y,N2,
N2,274Y,PMID:32750468,The H274Y mutation resulted in RI for the H5N6 NA and HRI for the H5N8 NA.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,oseltamivir,,middle,,N2,274Y,N2,
N2,274Y,PMID:32750468,The H274Y mutation resulted in RI for the H5N6 NA and HRI for the H5N8 NA.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:32750468,The H274Y mutation resulted in RI for the H5N6 NA and HRI for the H5N8 NA.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,peramivir,,high,,N2,274Y,N2,
N2,274Y,PMID:26292325,"Table 1 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (12,229.2-fold).",oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:29046464,"The H274Y substitution demonstrated highly reduced inhibition by OS (318.3-fold IC50 increase) and PER (114.9-fold IC50 increase), and of note, R292K showed highly reduced inhibition by all the NAIs tested (Table 1).Table 1 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (318.3-fold) , zanamivir (2.1-fold), and peramivir (114.9-fold).",oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:29046464,"The H274Y substitution demonstrated highly reduced inhibition by OS (318.3-fold IC50 increase) and PER (114.9-fold IC50 increase), and of note, R292K showed highly reduced inhibition by all the NAIs tested (Table 1).Table 1 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (318.3-fold) , zanamivir (2.1-fold), and peramivir (114.9-fold).",zanamivir,,low,,N2,274Y,N2,
N2,274Y,PMID:29046464,"The H274Y substitution demonstrated highly reduced inhibition by OS (318.3-fold IC50 increase) and PER (114.9-fold IC50 increase), and of note, R292K showed highly reduced inhibition by all the NAIs tested (Table 1).Table 1 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (318.3-fold) , zanamivir (2.1-fold), and peramivir (114.9-fold).",peramivir,,high,,N2,274Y,N2,
N2,274Y,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R274K reduced sensitivity to oseltamivir (1081.8-fold), zanamivir (2.7-fold), and peramivir (311.7-fold).",oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R274K reduced sensitivity to oseltamivir (1081.8-fold), zanamivir (2.7-fold), and peramivir (311.7-fold).",zanamivir,,low,,N2,274Y,N2,
N2,274Y,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R274K reduced sensitivity to oseltamivir (1081.8-fold), zanamivir (2.7-fold), and peramivir (311.7-fold).",peramivir,,high,,N2,274Y,N2,
N2,274Y,PMID:26292325,The addition of the H274Y mutation reduced inhibition by OS (17.4-fold) in N7 virus.,oseltamivir,,middle,,N2,274Y,N2,
N2,274Y,PMID:29046464,"Specifically, the H274Y mutant exhibited highly reduced inhibition by OS (425.1-fold IC50 increase) and PER (102.5-fold IC50 increase).",oseltamivir,,high,,N2,274Y,N2,
N2,274Y,PMID:29046464,"Specifically, the H274Y mutant exhibited highly reduced inhibition by OS (425.1-fold IC50 increase) and PER (102.5-fold IC50 increase).",peramivir,,high,,N2,274Y,N2,
N2,274Y,PMID:26292325,"When the H274Y mutation was added for comparison, the N9 virus had reduced inhibition by OS (90.3-fold) and PER (11.2-fold).Table 3 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (90.3-fold), zanamivir (2.4-fold), and peramivir (11.2-fold).",oseltamivir,,middle,,N2,274Y,N2,
N2,274Y,PMID:26292325,"When the H274Y mutation was added for comparison, the N9 virus had reduced inhibition by OS (90.3-fold) and PER (11.2-fold).Table 3 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (90.3-fold), zanamivir (2.4-fold), and peramivir (11.2-fold).",zanamivir,,low,,N2,274Y,N2,
N2,274Y,PMID:26292325,"When the H274Y mutation was added for comparison, the N9 virus had reduced inhibition by OS (90.3-fold) and PER (11.2-fold).Table 3 of the original text mentions that the NA mutation H274Y reduced sensitivity to oseltamivir (90.3-fold), zanamivir (2.4-fold), and peramivir (11.2-fold).",peramivir,,middle,,N2,274Y,N2,
N2,276D,PMID:16912325,The E276D virus conferred resistance to both oseltamivir carboxylate (>10-fold) and zanamivir (>100-fold) (Table 5).,oseltamivir,,middle,,N2,276D,N2,
N2,276D,PMID:16912325,The E276D virus conferred resistance to both oseltamivir carboxylate (>10-fold) and zanamivir (>100-fold) (Table 5).,zanamivir,,high,,N2,276D,N2,
N2,276D,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",oseltamivir,,middle,,N2,276D,N2,
N2,276D,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,high,,N2,276D,N2,
N2,276D,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",peramivir,,middle,,N2,276D,N2,
N2,276D,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,middle,,N2,276D,N2,
N2,276D,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,middle,,N2,276D,N2,
N2,276D,PMID:29046464,Virus with a single E276D substitution exhibited reduced inhibition by OS (10.6-fold 50% inhibitory concentration [IC50] increase) and PER (18.0-fold IC50 increase) and highly reduced inhibition by ZA (248.8-fold IC50 increase) compared to that of the N4 wild-type (WT) virus.,oseltamivir,,middle,,N2,276D,N2,
N2,276D,PMID:29046464,Virus with a single E276D substitution exhibited reduced inhibition by OS (10.6-fold 50% inhibitory concentration [IC50] increase) and PER (18.0-fold IC50 increase) and highly reduced inhibition by ZA (248.8-fold IC50 increase) compared to that of the N4 wild-type (WT) virus.,zanamivir,,high,,N2,276D,N2,
N2,276D,PMID:29046464,Virus with a single E276D substitution exhibited reduced inhibition by OS (10.6-fold 50% inhibitory concentration [IC50] increase) and PER (18.0-fold IC50 increase) and highly reduced inhibition by ZA (248.8-fold IC50 increase) compared to that of the N4 wild-type (WT) virus.,peramivir,,middle,,N2,276D,N2,
N2,276D,PMID:26292325,E276D is associated with reduced inhibition by ZA (13.6- to 25.9-fold) but normal inhibition by OS and PER (4.8- to 6.7-fold).,oseltamivir,,low,,N2,276D,N2,
N2,276D,PMID:26292325,E276D is associated with reduced inhibition by ZA (13.6- to 25.9-fold) but normal inhibition by OS and PER (4.8- to 6.7-fold).,zanamivir,,middle,,N2,276D,N2,
N2,276D,PMID:26292325,E276D is associated with reduced inhibition by ZA (13.6- to 25.9-fold) but normal inhibition by OS and PER (4.8- to 6.7-fold).,peramivir,,low,,N2,276D,N2,
N2,276D,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E276D shows reduced sensitivity to oseltamivir (13-fold), zanamivir (427-fold), peramivir (25-fold) and laninamivir (90-fold).",oseltamivir,,middle,,N2,276D,N2,
N2,276D,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E276D shows reduced sensitivity to oseltamivir (13-fold), zanamivir (427-fold), peramivir (25-fold) and laninamivir (90-fold).",zanamivir,,high,,N2,276D,N2,
N2,276D,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E276D shows reduced sensitivity to oseltamivir (13-fold), zanamivir (427-fold), peramivir (25-fold) and laninamivir (90-fold).",peramivir,,middle,,N2,276D,N2,
N2,276D,PMID:28934455,"Table 1 of the original text mentions that the virus with NA mutation E276D shows reduced sensitivity to oseltamivir (13-fold), zanamivir (427-fold), peramivir (25-fold) and laninamivir (90-fold).",laninamivir,,middle,,N2,276D,N2,
N2,291K,PMID:29046464,"The R292K mutant showed highly reduced inhibition mediated by OS (50,636,335.7-fold IC50 increase) and PER (8,540.4-fold IC50 increase) and reduced ZA-mediated inhibition (92.9-fold IC50 increase).",oseltamivir,,high,,N2,291K,N2,
N2,291K,PMID:29046464,"The R292K mutant showed highly reduced inhibition mediated by OS (50,636,335.7-fold IC50 increase) and PER (8,540.4-fold IC50 increase) and reduced ZA-mediated inhibition (92.9-fold IC50 increase).",zanamivir,,middle,,N2,291K,N2,
N2,291K,PMID:29046464,"The R292K mutant showed highly reduced inhibition mediated by OS (50,636,335.7-fold IC50 increase) and PER (8,540.4-fold IC50 increase) and reduced ZA-mediated inhibition (92.9-fold IC50 increase).",peramivir,,high,,N2,291K,N2,
N2,292K,PMID:32004620,"One virus with NA R292K substitution was isolated from a hospitalized patient in Australia and showed remarkable HRI, 7735-fold increase in IC50, by oseltamivir and RI by peramivir.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution R292K exhibits reduced sensitivity to oseltamivir (7735-fold), zanamivir (6.6-fold) and peramivir (60-fold).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:32004620,"One virus with NA R292K substitution was isolated from a hospitalized patient in Australia and showed remarkable HRI, 7735-fold increase in IC50, by oseltamivir and RI by peramivir.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution R292K exhibits reduced sensitivity to oseltamivir (7735-fold), zanamivir (6.6-fold) and peramivir (60-fold).",zanamivir,,low,,N2,292K,N2,
N2,292K,PMID:32004620,"One virus with NA R292K substitution was isolated from a hospitalized patient in Australia and showed remarkable HRI, 7735-fold increase in IC50, by oseltamivir and RI by peramivir.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution R292K exhibits reduced sensitivity to oseltamivir (7735-fold), zanamivir (6.6-fold) and peramivir (60-fold).",peramivir,,middle,,N2,292K,N2,
N2,292K,PMID:30910698,"The R292 K mutation reduced oseltamivir susceptibility significantly (2,523-fold) and moderately reduced susceptibility to zanamivir.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:30910698,"The R292 K mutation reduced oseltamivir susceptibility significantly (2,523-fold) and moderately reduced susceptibility to zanamivir.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:32750468,"The R292K mutation in H5N2 resulted in HRI for OSE.The H5N2_R292K virus demonstrated RI to ZAN.The IC50 measurements made using the MUNANA assay for PER with the panel of H5N6 mutants did not show any alteration in susceptibility to the drug, and for the H5N2 panel only the R292K showed RI for PER.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:32750468,"The R292K mutation in H5N2 resulted in HRI for OSE.The H5N2_R292K virus demonstrated RI to ZAN.The IC50 measurements made using the MUNANA assay for PER with the panel of H5N6 mutants did not show any alteration in susceptibility to the drug, and for the H5N2 panel only the R292K showed RI for PER.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:32750468,"The R292K mutation in H5N2 resulted in HRI for OSE.The H5N2_R292K virus demonstrated RI to ZAN.The IC50 measurements made using the MUNANA assay for PER with the panel of H5N6 mutants did not show any alteration in susceptibility to the drug, and for the H5N2 panel only the R292K showed RI for PER.",peramivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,Please refer to Table 1 of the original article for the specific fold change values.,oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,Please refer to Table 1 of the original article for the specific fold change values.,peramivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In contrast, the E119D and R292K substitutions in the N6 subtype exhibited HRI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,292K,N2,
N2,292K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Viruses with the R292K substitution are frequently resistant to all NAIs. Please refer to Table 1 of the original article for the specific fold change values.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Viruses with the R292K substitution are frequently resistant to all NAIs. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Viruses with the R292K substitution are frequently resistant to all NAIs. Please refer to Table 1 of the original article for the specific fold change values.",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:33055248,"In the N8 subtype, Q136K and R292K substitutions caused HRI by LAN, whereas the G147V substitution yielded RI. Viruses with the R292K substitution are frequently resistant to all NAIs. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,high,,N2,292K,N2,
N2,292K,PMID:32750468,"The highest concentration of OSE (10 μM) completely abrogated plaque formation of wt H5N6, whereas no reduction in plaque size was observed for H5N6_R292K (Fig. 2J & M) which suggests HRI of R292K virus to OSE.In the plaque reduction assay the H5N6_R292K virus showed a 40% reduction in plaque size (10 μM of ZAN) compared to no drug, giving the phenotype of HRI when compared to wt H5N6.In the plaque reduction assay addition of 10 μM PER reduced the plaque size of the H5N6_R292K by approximately 40%, and thus resulted in HRI when compared to the 100% reduction in wt H5N6 virus",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:32750468,"The highest concentration of OSE (10 μM) completely abrogated plaque formation of wt H5N6, whereas no reduction in plaque size was observed for H5N6_R292K (Fig. 2J & M) which suggests HRI of R292K virus to OSE.In the plaque reduction assay the H5N6_R292K virus showed a 40% reduction in plaque size (10 μM of ZAN) compared to no drug, giving the phenotype of HRI when compared to wt H5N6.In the plaque reduction assay addition of 10 μM PER reduced the plaque size of the H5N6_R292K by approximately 40%, and thus resulted in HRI when compared to the 100% reduction in wt H5N6 virus",zanamivir,,high,,N2,292K,N2,
N2,292K,PMID:32750468,"The highest concentration of OSE (10 μM) completely abrogated plaque formation of wt H5N6, whereas no reduction in plaque size was observed for H5N6_R292K (Fig. 2J & M) which suggests HRI of R292K virus to OSE.In the plaque reduction assay the H5N6_R292K virus showed a 40% reduction in plaque size (10 μM of ZAN) compared to no drug, giving the phenotype of HRI when compared to wt H5N6.In the plaque reduction assay addition of 10 μM PER reduced the plaque size of the H5N6_R292K by approximately 40%, and thus resulted in HRI when compared to the 100% reduction in wt H5N6 virus",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:26292325,"R292K, which was selected by OS, highly reduced inhibition by OS (17,959.7-fold), and reduced inhibition by ZA (22.5-fold) and PER (41.1-fold) compared to that of the parental N3 virus.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:26292325,"R292K, which was selected by OS, highly reduced inhibition by OS (17,959.7-fold), and reduced inhibition by ZA (22.5-fold) and PER (41.1-fold) compared to that of the parental N3 virus.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:26292325,"R292K, which was selected by OS, highly reduced inhibition by OS (17,959.7-fold), and reduced inhibition by ZA (22.5-fold) and PER (41.1-fold) compared to that of the parental N3 virus.",peramivir,,middle,,N2,292K,N2,
N2,292K,PMID:29046464,"R292K showed highly reduced inhibition by all the NAIs tested (Table 1). Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (52,862,135.4-fold), zanamivir (465.3-fold), and peramivir (30251.7-fold).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"R292K showed highly reduced inhibition by all the NAIs tested (Table 1). Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (52,862,135.4-fold), zanamivir (465.3-fold), and peramivir (30251.7-fold).",zanamivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"R292K showed highly reduced inhibition by all the NAIs tested (Table 1). Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (52,862,135.4-fold), zanamivir (465.3-fold), and peramivir (30251.7-fold).",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (963.7-fold), zanamivir (3.9-fold), and peramivir (283.7-fold).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (963.7-fold), zanamivir (3.9-fold), and peramivir (283.7-fold).",zanamivir,,low,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses carrying both H274Y and R292K substitutions demonstrated highly reduced OS-mediated (1081.8- and 963.7-fold IC50 increases, respectively) and PER-mediated (311.7- and 283.7-fold IC50 increases, respectively) inhibition compared to that of the N5 WT virus but normal inhibition by ZA. Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (963.7-fold), zanamivir (3.9-fold), and peramivir (283.7-fold).",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses with R292K and R371K substitutions showed reduced or highly reduced inhibition by all the NAIs tested.Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (15,067.8-fold), zanamivir (45.5-fold), and peramivir (844.3-fold).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses with R292K and R371K substitutions showed reduced or highly reduced inhibition by all the NAIs tested.Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (15,067.8-fold), zanamivir (45.5-fold), and peramivir (844.3-fold).",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:29046464,"Viruses with R292K and R371K substitutions showed reduced or highly reduced inhibition by all the NAIs tested.Table 1 of the original text mentions that the NA mutation R292K reduced sensitivity to oseltamivir (15,067.8-fold), zanamivir (45.5-fold), and peramivir (844.3-fold).",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:26292325,"Notably, R292K conferred highly reduced inhibition to both OS (44,326.4-fold) and PER (414.8-fold) and reduced inhibition to ZA (21.1-fold).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:26292325,"Notably, R292K conferred highly reduced inhibition to both OS (44,326.4-fold) and PER (414.8-fold) and reduced inhibition to ZA (21.1-fold).",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:26292325,"Notably, R292K conferred highly reduced inhibition to both OS (44,326.4-fold) and PER (414.8-fold) and reduced inhibition to ZA (21.1-fold).",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:31132385,"Substitution R292K in NA, which was selected in vitro following passage in the presence of oseltamivir or peramivir, led to significant susceptibility changes, with a >1000-fold increase in oseltamivir and peramivir IC50 and a 41-fold & 21-fold increase in zanamivir and laninamivir IC50 respectively, compared to wild-type (WT) NA",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:31132385,"Substitution R292K in NA, which was selected in vitro following passage in the presence of oseltamivir or peramivir, led to significant susceptibility changes, with a >1000-fold increase in oseltamivir and peramivir IC50 and a 41-fold & 21-fold increase in zanamivir and laninamivir IC50 respectively, compared to wild-type (WT) NA",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:31132385,"Substitution R292K in NA, which was selected in vitro following passage in the presence of oseltamivir or peramivir, led to significant susceptibility changes, with a >1000-fold increase in oseltamivir and peramivir IC50 and a 41-fold & 21-fold increase in zanamivir and laninamivir IC50 respectively, compared to wild-type (WT) NA",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:31132385,"Substitution R292K in NA, which was selected in vitro following passage in the presence of oseltamivir or peramivir, led to significant susceptibility changes, with a >1000-fold increase in oseltamivir and peramivir IC50 and a 41-fold & 21-fold increase in zanamivir and laninamivir IC50 respectively, compared to wild-type (WT) NA",laninamivir,,middle,,N2,292K,N2,
N2,292K,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50.",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50.",zanamivir,,middle,,N2,292K,N2,
N2,292K,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50.",peramivir,,high,,N2,292K,N2,
N2,292K,PMID:31132385,"The results in Table 2 show that in the Pearl-NA background, similar to the Anhui/1 NA background, R292K leads to a greater than 1000-fold increase in oseltamivir and peramivir IC50.",laninamivir,,low,,N2,292K,N2,
N2,292K,PMID:26292325,"However, the R292K mutation conferred resistance to all NAIs tested (68,891.1-fold to OS, 51.3-fold to ZA, and 2,067.9-fold to PER).",oseltamivir,,high,,N2,292K,N2,
N2,292K,PMID:26292325,"However, the R292K mutation conferred resistance to all NAIs tested (68,891.1-fold to OS, 51.3-fold to ZA, and 2,067.9-fold to PER).",peramivir,,high,,N2,292K,N2,
N2,293N,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",oseltamivir,,middle,,N2,293N,N2,
N2,293N,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,293N,N2,
N2,293N,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN. Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,293N,N2,
N2,293N,PMID:26292325,D293N conferred reduced inhibition by OS (13.5-fold) and ZA (57.3-fold) without affecting susceptibility to PER (5.4-fold).,oseltamivir,,middle,,N2,293N,N2,
N2,293N,PMID:26292325,D293N conferred reduced inhibition by OS (13.5-fold) and ZA (57.3-fold) without affecting susceptibility to PER (5.4-fold).,zanamivir,,middle,,N2,293N,N2,
N2,293N,PMID:26292325,D293N conferred reduced inhibition by OS (13.5-fold) and ZA (57.3-fold) without affecting susceptibility to PER (5.4-fold).,peramivir,,low,,N2,293N,N2,
N2,294S,PMID:28458567,"Table 1 of the original text mentions that the NA mutation N294S in subtype pH1N1 shows reduced sensitivity to oseltamivir (124-208-fold), zanamivir (3-9-fold) and peramivir (12-fold).",oseltamivir,,high,,N2,294S,N2,
N2,294S,PMID:28458567,"Table 1 of the original text mentions that the NA mutation N294S in subtype pH1N1 shows reduced sensitivity to oseltamivir (124-208-fold), zanamivir (3-9-fold) and peramivir (12-fold).",zanamivir,,low,,N2,294S,N2,
N2,294S,PMID:28458567,"Table 1 of the original text mentions that the NA mutation N294S in subtype pH1N1 shows reduced sensitivity to oseltamivir (124-208-fold), zanamivir (3-9-fold) and peramivir (12-fold).",peramivir,,middle,,N2,294S,N2,
N2,294S,PMID:32750468,"The results of MUNANA assay with ZAN showed that E119V mutation conferred HRI only in H5N8 virus, N294S mutation led to RI in H5N6 and H5N2 backgrounds and H274Y substitution did not affect the susceptibility to ZAN in any of the H5Nx viruses.",zanamivir,,middle,,N2,294S,N2,
N2,294S,PMID:24215378,Table 1 of the original text indicates that the NA mutation N294S in subtype A(H3N2) confers highly reduced inhibition (>100-fold increase in IC50 over WT) to oseltamivir and susceptibility or normal inhibition (<10-fold increase in IC50 over WT) to zanamivir.,oseltamivir,,high,,N2,294S,N2,
N2,294S,PMID:32750468,"The results of MUNANA assay with ZAN showed that E119V mutation conferred HRI only in H5N8 virus, N294S mutation led to RI in H5N6 and H5N2 backgrounds and H274Y substitution did not affect the susceptibility to ZAN in any of the H5Nx viruses",zanamivir,,middle,,N2,294S,N2,
N2,294S,PMID:25320319,Table 1 of the original text mentions that the NA mutation N294S reduced sensitivity to oseltamivir (63.6-fold) and peramivir (2.5-fold).,oseltamivir,,middle,,N2,294S,N2,
N2,294S,PMID:25320319,Table 1 of the original text mentions that the NA mutation N294S reduced sensitivity to oseltamivir (63.6-fold) and peramivir (2.5-fold).,peramivir,,low,,N2,294S,N2,
N2,294S,PMID:32750468,N294S mutation showed RI only in H5N8 background.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,oseltamivir,,middle,,N2,294S,N2,
N2,294S,PMID:32750468,N294S mutation showed RI only in H5N8 background.H5N8_E119V and H5N8_H274Y viruses both displayed HRI for PER whereas H5N8_N294S showed a more modest RI to the drug.,peramivir,,middle,,N2,294S,N2,
N2,294S,PMID:28934455,Table 1 of the original text mentions that the virus with NA mutation N294S shows reduced sensitivity to zanamivir (10-fold) and laninamivir (3-fold).,zanamivir,,low,,N2,294S,N2,
N2,294S,PMID:28934455,Table 1 of the original text mentions that the virus with NA mutation N294S shows reduced sensitivity to zanamivir (10-fold) and laninamivir (3-fold).,laninamivir,,low,,N2,294S,N2,
N2,313A,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution V313A exhibits reduced sensitivity to oseltamivir (7.8–9.9-fold), zanamivir (4.3–5.0-fold), peramivir (10.5–11-fold) and laninamivir (2.3-fold).",oseltamivir,,low,,N2,313A,N2,
N2,313A,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution V313A exhibits reduced sensitivity to oseltamivir (7.8–9.9-fold), zanamivir (4.3–5.0-fold), peramivir (10.5–11-fold) and laninamivir (2.3-fold).",zanamivir,,low,,N2,313A,N2,
N2,313A,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution V313A exhibits reduced sensitivity to oseltamivir (7.8–9.9-fold), zanamivir (4.3–5.0-fold), peramivir (10.5–11-fold) and laninamivir (2.3-fold).",peramivir,,middle,,N2,313A,N2,
N2,320E,PMID:28458567,"Table 1 of the original text mentions that the NA mutation G320E in subtype H5N1 shows reduced sensitivity to oseltamivir (17-fold), zanamivir (8.4-fold) and peramivir (3.3-fold).",oseltamivir,,middle,,N2,320E,N2,
N2,320E,PMID:28458567,"Table 1 of the original text mentions that the NA mutation G320E in subtype H5N1 shows reduced sensitivity to oseltamivir (17-fold), zanamivir (8.4-fold) and peramivir (3.3-fold).",zanamivir,,low,,N2,320E,N2,
N2,320E,PMID:28458567,"Table 1 of the original text mentions that the NA mutation G320E in subtype H5N1 shows reduced sensitivity to oseltamivir (17-fold), zanamivir (8.4-fold) and peramivir (3.3-fold).",peramivir,,low,,N2,320E,N2,
N2,320R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution G320R exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (16-fold) and laninamivir (4.1-fold).",oseltamivir,,middle,,N2,320R,N2,
N2,320R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution G320R exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (16-fold) and laninamivir (4.1-fold).",zanamivir,,middle,,N2,320R,N2,
N2,320R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution G320R exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (16-fold) and laninamivir (4.1-fold).",laninamivir,,low,,N2,320R,N2,
N2,329K,PMID:33202972,The H1avN2 strains with N2 of human seasonal origin were the only ones harboring mutation NA-N329K classified RI to oseltamivir and zanamivir,oseltamivir,,middle,,N2,329K,N2,
N2,329K,PMID:33202972,The H1avN2 strains with N2 of human seasonal origin were the only ones harboring mutation NA-N329K classified RI to oseltamivir and zanamivir,zanamivir,,middle,,N2,329K,N2,
N2,329K,PMID:25721488,Table 1 of the original text mentions that the virus A(H3N2) with NA mutation N329K shows reduced sensitivity to oseltamivir (10-fold) and zanamivir (11-fold).,oseltamivir,,low,,N2,329K,N2,
N2,329K,PMID:25721488,Table 1 of the original text mentions that the virus A(H3N2) with NA mutation N329K shows reduced sensitivity to oseltamivir (10-fold) and zanamivir (11-fold).,zanamivir,,middle,,N2,329K,N2,
N2,329R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N329R exhibits reduced sensitivity to oseltamivir (29-fold), zanamivir (19-fold), peramivir (3.0-fold) and laninamivir (2.7-fold).",oseltamivir,,middle,,N2,329R,N2,
N2,329R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N329R exhibits reduced sensitivity to oseltamivir (29-fold), zanamivir (19-fold), peramivir (3.0-fold) and laninamivir (2.7-fold).",zanamivir,,middle,,N2,329R,N2,
N2,329R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N329R exhibits reduced sensitivity to oseltamivir (29-fold), zanamivir (19-fold), peramivir (3.0-fold) and laninamivir (2.7-fold).",peramivir,,low,,N2,329R,N2,
N2,329R,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N329R exhibits reduced sensitivity to oseltamivir (29-fold), zanamivir (19-fold), peramivir (3.0-fold) and laninamivir (2.7-fold).",laninamivir,,low,,N2,329R,N2,
N2,331R,PMID:33202972,"By contrast, 80% of H1huN2 strains harbored mutation NA-S331R, also classified as RI to oseltamivir and zanamivir.",oseltamivir,,middle,,N2,331R,N2,
N2,331R,PMID:33202972,"By contrast, 80% of H1huN2 strains harbored mutation NA-S331R, also classified as RI to oseltamivir and zanamivir.",zanamivir,,middle,,N2,331R,N2,
N2,331R,PMID:25721488,Table 1 of the original text mentions that the virus A(H3N2) with NA mutation S331R shows reduced sensitivity to zanamivir (7.8-fold).,oseltamivir,,middle,,N2,331R,N2,
N2,331R,PMID:25721488,Table 1 of the original text mentions that the virus A(H3N2) with NA mutation S331R shows reduced sensitivity to zanamivir (7.8-fold).,zanamivir,,low,,N2,331R,N2,
N2,331S,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,low,,N2,331S,N2,
N2,333G,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S333G exhibits reduced sensitivity to oseltamivir (20–24-fold), zanamivir (14–15-fold), peramivir (3.9–5.1-fold) and laninamivir (3.0–3.3-fold).",oseltamivir,,middle,,N2,333G,N2,
N2,333G,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S333G exhibits reduced sensitivity to oseltamivir (20–24-fold), zanamivir (14–15-fold), peramivir (3.9–5.1-fold) and laninamivir (3.0–3.3-fold).",zanamivir,,middle,,N2,333G,N2,
N2,333G,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S333G exhibits reduced sensitivity to oseltamivir (20–24-fold), zanamivir (14–15-fold), peramivir (3.9–5.1-fold) and laninamivir (3.0–3.3-fold).",peramivir,,low,,N2,333G,N2,
N2,333G,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S333G exhibits reduced sensitivity to oseltamivir (20–24-fold), zanamivir (14–15-fold), peramivir (3.9–5.1-fold) and laninamivir (3.0–3.3-fold).",laninamivir,,low,,N2,333G,N2,
N2,334R,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S334R exhibits reduced sensitivity to oseltamivir (14-fold) and zanamivir (4.9-fold).",oseltamivir,,middle,,N2,334R,N2,
N2,334R,PMID:32004620,"NA S333G and NA S334R substitutions conferred RI by oseltamivir and zanamivir or RI by oseltamivir, respectively.Table 1 of the original text mentions that the virus A(H3N2) with NA substitution S334R exhibits reduced sensitivity to oseltamivir (14-fold) and zanamivir (4.9-fold).",zanamivir,,low,,N2,334R,N2,
N2,342K,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N342K exhibits reduced sensitivity to oseltamivir (10.1-fold), zanamivir (9.3-fold), peramivir (5.3-fold) and laninamivir (2.9-fold).",oseltamivir,,middle,,N2,342K,N2,
N2,342K,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N342K exhibits reduced sensitivity to oseltamivir (10.1-fold), zanamivir (9.3-fold), peramivir (5.3-fold) and laninamivir (2.9-fold).",zanamivir,,low,,N2,342K,N2,
N2,342K,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N342K exhibits reduced sensitivity to oseltamivir (10.1-fold), zanamivir (9.3-fold), peramivir (5.3-fold) and laninamivir (2.9-fold).",peramivir,,low,,N2,342K,N2,
N2,342K,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution N342K exhibits reduced sensitivity to oseltamivir (10.1-fold), zanamivir (9.3-fold), peramivir (5.3-fold) and laninamivir (2.9-fold).",laninamivir,,low,,N2,342K,N2,
N2,371K,PMID:16912325,The R371K virus conferred resistance to both oseltamivir carboxylate (∼45-fold) and zanamivir (∼15-fold) (Table 2).,oseltamivir,,middle,,N2,371K,N2,
N2,371K,PMID:16912325,The R371K virus conferred resistance to both oseltamivir carboxylate (∼45-fold) and zanamivir (∼15-fold) (Table 2).,zanamivir,,middle,,N2,371K,N2,
N2,371K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",oseltamivir,,middle,,N2,371K,N2,
N2,371K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",zanamivir,,middle,,N2,371K,N2,
N2,371K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",peramivir,,middle,,N2,371K,N2,
N2,371K,PMID:33055248,"These included the E119G substitution in N3; A246V and R371K in N6; E119G, S111N-E119D, E119D, R292K, and D293N in N7; and Q136K and R292K in N9, which demonstrated RI by LAN.Please refer to Table 2 of the original article for the specific fold change values.",laninamivir,,middle,,N2,371K,N2,
N2,371K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",oseltamivir,,middle,,N2,371K,N2,
N2,371K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",zanamivir,,middle,,N2,371K,N2,
N2,371K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",peramivir,,middle,,N2,371K,N2,
N2,371K,PMID:28934455,"Notably, 2 of these, R371K at the functional residue and I222K at the framework, conferred RI(100>Fold change >10 , RI) by all 4 NA inhibitors. (oseltamivir,zanamivir,peramivir,laninamivir)",laninamivir,,middle,,N2,371K,N2,
N2,372K,PMID:29046464,"Viruses with R292K and R371K substitutions showed reduced or highly reduced inhibition by all the NAIs tested.Table 1 of the original text mentions that the NA mutation R371K reduced sensitivity to oseltamivir (23.3-fold), zanamivir (52.7-fold), and peramivir (11.8-fold).",oseltamivir,,middle,,N2,372K,N2,
N2,372K,PMID:29046464,"Viruses with R292K and R371K substitutions showed reduced or highly reduced inhibition by all the NAIs tested.Table 1 of the original text mentions that the NA mutation R371K reduced sensitivity to oseltamivir (23.3-fold), zanamivir (52.7-fold), and peramivir (11.8-fold).",zanamivir,,middle,,N2,372K,N2,
N2,379E,PMID:29046464,Table 1 of the original text mentions that the NA mutation D379E reduced sensitivity to zanamivir (2.1-fold) and peramivir (2.2-fold).,zanamivir,,low,,N2,379E,N2,
N2,379E,PMID:29046464,Table 1 of the original text mentions that the NA mutation D379E reduced sensitivity to zanamivir (2.1-fold) and peramivir (2.2-fold).,peramivir,,low,,N2,379E,N2,
N2,387K,PMID:31132385,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,low,,N2,387K,N2,
N2,391K,PMID:28802866,"Table 1 of the original text mentions that the NA substitution Q391K reduced sensitivity to oseltamivir (87.0-fold), zanamivir (32.0-fold), peramivir (16.0-fold) and laninamivir (9.0-fold).",oseltamivir,,middle,,N2,391K,N2,
N2,391K,PMID:28802866,"Table 1 of the original text mentions that the NA substitution Q391K reduced sensitivity to oseltamivir (87.0-fold), zanamivir (32.0-fold), peramivir (16.0-fold) and laninamivir (9.0-fold).",zanamivir,,middle,,N2,391K,N2,
N2,41G,PMID:16801417,Table 4 of the original text mentions that the NA mutation E41G reduced sensitivity to oseltamivir (11.7-fold).,oseltamivir,,middle,,N2,41G,N2,
N2,427L,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",oseltamivir,,middle,,N2,427L,N2,
N2,427L,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",zanamivir,,middle,,N2,427L,N2,
N2,427L,PMID:33055248,"Viruses with E276D and I427L substitutions in the N4 subtype exhibited reduced inhibition (RI), and R292K imparted HRI by LAN. Please refer to Table 1 of the original article for the specific fold change values.",laninamivir,,middle,,N2,427L,N2,
N2,427L,PMID:29046464,"Virus carrying the I427L substitution showed reduced inhibition by OS (18.8-fold IC50 increase) and ZA (75.5-fold IC50 increase) compared to the N4 WT virus.Table 1 of the original text mentions that the NA mutation I427L reduced sensitivity to oseltamivir (18.8-fold), zanamivir (75.5-fold), and peramivir (8.9-fold).",oseltamivir,,middle,,N2,427L,N2,
N2,427L,PMID:29046464,"Virus carrying the I427L substitution showed reduced inhibition by OS (18.8-fold IC50 increase) and ZA (75.5-fold IC50 increase) compared to the N4 WT virus.Table 1 of the original text mentions that the NA mutation I427L reduced sensitivity to oseltamivir (18.8-fold), zanamivir (75.5-fold), and peramivir (8.9-fold).",zanamivir,,middle,,N2,427L,N2,
N2,427L,PMID:29046464,"Virus carrying the I427L substitution showed reduced inhibition by OS (18.8-fold IC50 increase) and ZA (75.5-fold IC50 increase) compared to the N4 WT virus.Table 1 of the original text mentions that the NA mutation I427L reduced sensitivity to oseltamivir (18.8-fold), zanamivir (75.5-fold), and peramivir (8.9-fold).",peramivir,,middle,,N2,427L,N2,
N2,463N,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D463N exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (8.8-fold), peramivir (13-fold) and laninamivir (2.9-fold).",oseltamivir,,middle,,N2,463N,N2,
N2,463N,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D463N exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (8.8-fold), peramivir (13-fold) and laninamivir (2.9-fold).",zanamivir,,low,,N2,463N,N2,
N2,463N,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D463N exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (8.8-fold), peramivir (13-fold) and laninamivir (2.9-fold).",peramivir,,middle,,N2,463N,N2,
N2,463N,PMID:32004620,"Table 1 of the original text mentions that the virus A(H3N2) with NA substitution D463N exhibits reduced sensitivity to oseltamivir (16-fold), zanamivir (8.8-fold), peramivir (13-fold) and laninamivir (2.9-fold).",laninamivir,,low,,N2,463N,N2,
NA(B type),104E,PMID:28802866,"Table 2 of the original text mentions that the NA substitution G104E reduced sensitivity to oseltamivir (87.0-fold), zanamivir (1220.0-fold), peramivir (17724.0-fold) and laninamivir (701.0-fold).",oseltamivir,,high,,NA(B type),104E,NA(B type),
NA(B type),104E,PMID:28802866,"Table 2 of the original text mentions that the NA substitution G104E reduced sensitivity to oseltamivir (87.0-fold), zanamivir (1220.0-fold), peramivir (17724.0-fold) and laninamivir (701.0-fold).",zanamivir,,high,,NA(B type),104E,NA(B type),
NA(B type),104E,PMID:28802866,"Table 2 of the original text mentions that the NA substitution G104E reduced sensitivity to oseltamivir (87.0-fold), zanamivir (1220.0-fold), peramivir (17724.0-fold) and laninamivir (701.0-fold).",peramivir,,high,,NA(B type),104E,NA(B type),
NA(B type),104E,PMID:28802866,"Table 2 of the original text mentions that the NA substitution G104E reduced sensitivity to oseltamivir (87.0-fold), zanamivir (1220.0-fold), peramivir (17724.0-fold) and laninamivir (701.0-fold).",laninamivir,,high,,NA(B type),104E,NA(B type),
NA(B type),105K,PMID:28802866,"Table 2 of the original text mentions that the NA substitution E105K/E reduced sensitivity to oseltamivir (4.6-fold), zanamivir (3.0-fold), peramivir (59.0-fold) and laninamivir (2.1-fold).",oseltamivir,,low,,NA(B type),105K,NA(B type),
NA(B type),105K,PMID:28802866,"Table 2 of the original text mentions that the NA substitution E105K/E reduced sensitivity to oseltamivir (4.6-fold), zanamivir (3.0-fold), peramivir (59.0-fold) and laninamivir (2.1-fold).",zanamivir,,low,,NA(B type),105K,NA(B type),
NA(B type),105K,PMID:28802866,"Table 2 of the original text mentions that the NA substitution E105K/E reduced sensitivity to oseltamivir (4.6-fold), zanamivir (3.0-fold), peramivir (59.0-fold) and laninamivir (2.1-fold).",peramivir,,high,,NA(B type),105K,NA(B type),
NA(B type),105K,PMID:28802866,"Table 2 of the original text mentions that the NA substitution E105K/E reduced sensitivity to oseltamivir (4.6-fold), zanamivir (3.0-fold), peramivir (59.0-fold) and laninamivir (2.1-fold).",laninamivir,,low,,NA(B type),105K,NA(B type),
NA(B type),115T,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution I115T exhibits reduced sensitivity to peramivir (6.9-fold).,peramivir,,middle,,NA(B type),115T,NA(B type),
NA(B type),115T,PMID:30771405,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,NA(B type),115T,NA(B type),
NA(B type),117G,PMID:32004620,"One virus with NA E117G substitution, showing HRI with high fold increases in IC50 values for zanamivir (1250-fold), peramivir (2778-fold) and laninamivir (971-fold), and RI by oseltamivir, was isolated from a patient in Canada but patient information was unavailable.",oseltamivir,,middle,,NA(B type),117G,NA(B type),
NA(B type),117G,PMID:32004620,"One virus with NA E117G substitution, showing HRI with high fold increases in IC50 values for zanamivir (1250-fold), peramivir (2778-fold) and laninamivir (971-fold), and RI by oseltamivir, was isolated from a patient in Canada but patient information was unavailable.",zanamivir,,high,,NA(B type),117G,NA(B type),
NA(B type),117G,PMID:32004620,"One virus with NA E117G substitution, showing HRI with high fold increases in IC50 values for zanamivir (1250-fold), peramivir (2778-fold) and laninamivir (971-fold), and RI by oseltamivir, was isolated from a patient in Canada but patient information was unavailable.",peramivir,,high,,NA(B type),117G,NA(B type),
NA(B type),117G,PMID:32004620,"One virus with NA E117G substitution, showing HRI with high fold increases in IC50 values for zanamivir (1250-fold), peramivir (2778-fold) and laninamivir (971-fold), and RI by oseltamivir, was isolated from a patient in Canada but patient information was unavailable.",laninamivir,,high,,NA(B type),117G,NA(B type),
NA(B type),131A,PMID:30771405,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,high,,NA(B type),131A,NA(B type),
NA(B type),134N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution H134N reduced sensitivity to oseltamivir (4.1-4.6-fold), zanamivir (121-159.0-fold), peramivir (100-131.0-fold) and laninamivir (49-53.0-fold).",oseltamivir,,low,,NA(B type),134N,NA(B type),
NA(B type),134N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution H134N reduced sensitivity to oseltamivir (4.1-4.6-fold), zanamivir (121-159.0-fold), peramivir (100-131.0-fold) and laninamivir (49-53.0-fold).",zanamivir,,high,,NA(B type),134N,NA(B type),
NA(B type),134N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution H134N reduced sensitivity to oseltamivir (4.1-4.6-fold), zanamivir (121-159.0-fold), peramivir (100-131.0-fold) and laninamivir (49-53.0-fold).",peramivir,,high,,NA(B type),134N,NA(B type),
NA(B type),134N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution H134N reduced sensitivity to oseltamivir (4.1-4.6-fold), zanamivir (121-159.0-fold), peramivir (100-131.0-fold) and laninamivir (49-53.0-fold).",laninamivir,,middle,,NA(B type),134N,NA(B type),
NA(B type),134R,PMID:32750469,The H134R virus had the highest resistance to peramivir and zanamivir of all the variants isolated (>1000 nM and >300-fold to both).,oseltamivir,,low,,NA(B type),134R,NA(B type),
NA(B type),134R,PMID:32750469,The H134R virus had the highest resistance to peramivir and zanamivir of all the variants isolated (>1000 nM and >300-fold to both).,zanamivir,,high,,NA(B type),134R,NA(B type),
NA(B type),134R,PMID:32750469,The H134R virus had the highest resistance to peramivir and zanamivir of all the variants isolated (>1000 nM and >300-fold to both).,peramivir,,high,,NA(B type),134R,NA(B type),
NA(B type),134Y,PMID:32750469,"As seen with the B/Auckland virus, this virus was less sensitive to oseltamivir and peramivir (4-fold and 92-fold respectively), but showed enhanced sensitivity to zanamivir (3-fold), confirming the unusual phenotype of the H134Y viruses.",oseltamivir,,low,,NA(B type),134Y,NA(B type),
NA(B type),134Y,PMID:32750469,"As seen with the B/Auckland virus, this virus was less sensitive to oseltamivir and peramivir (4-fold and 92-fold respectively), but showed enhanced sensitivity to zanamivir (3-fold), confirming the unusual phenotype of the H134Y viruses.",zanamivir,,low,,NA(B type),134Y,NA(B type),
NA(B type),134Y,PMID:32750469,"As seen with the B/Auckland virus, this virus was less sensitive to oseltamivir and peramivir (4-fold and 92-fold respectively), but showed enhanced sensitivity to zanamivir (3-fold), confirming the unusual phenotype of the H134Y viruses.",peramivir,,high,,NA(B type),134Y,NA(B type),
NA(B type),142H,PMID:25043638,Table 2 of the original text mentions that the NA substitution Y142H reduced sensitivity to oseltamivir (2.9-fold) and peramivir (6.0-fold).,oseltamivir,,low,,NA(B type),142H,NA(B type),
NA(B type),142H,PMID:25043638,Table 2 of the original text mentions that the NA substitution Y142H reduced sensitivity to oseltamivir (2.9-fold) and peramivir (6.0-fold).,peramivir,,middle,,NA(B type),142H,NA(B type),
NA(B type),145E,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution G145E exhibits reduced sensitivity to peramivir (4-fold).,peramivir,,low,,NA(B type),145E,NA(B type),
NA(B type),145E,PMID:32004620,NA G145E showed RI by peramivir and the substitution was detected in the clinical specimen.,peramivir,,middle,,NA(B type),145E,NA(B type),
NA(B type),146I,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution T146I exhibits reduced sensitivity to oseltamivir (2.1-fold) and peramivir (134-fold).,oseltamivir,,low,,NA(B type),146I,NA(B type),
NA(B type),146I,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution T146I exhibits reduced sensitivity to oseltamivir (2.1-fold) and peramivir (134-fold).,peramivir,,high,,NA(B type),146I,NA(B type),
NA(B type),150K,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution R150K exhibits reduced sensitivity to oseltamivir (47-fold) and zanamivir (29-fold).,oseltamivir,,middle,,NA(B type),150K,NA(B type),
NA(B type),150K,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution R150K exhibits reduced sensitivity to oseltamivir (47-fold) and zanamivir (29-fold).,zanamivir,,middle,,NA(B type),150K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in CL assay reduced sensitivity to zanamivir (154.0-fold) and oseltamivir (163.9-fold).,oseltamivir,,high,,NA(B type),152K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in CL assay reduced sensitivity to zanamivir (154.0-fold) and oseltamivir (163.9-fold).,zanamivir,,high,,NA(B type),152K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in FA-1 assay reduced sensitivity to zanamivir (147.8-fold) and oseltamivir (31-fold).,oseltamivir,,high,,NA(B type),152K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in FA-1 assay reduced sensitivity to zanamivir (147.8-fold) and oseltamivir (31-fold).,zanamivir,,middle,,NA(B type),152K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in FA-2 assay reduced sensitivity to zanamivir (44.1-fold) and oseltamivir (12.5-fold).,oseltamivir,,high,,NA(B type),152K,NA(B type),
NA(B type),152K,PMID:12574276,Table 4 of the original text mentions that the NA substitution R152K in FA-2 assay reduced sensitivity to zanamivir (44.1-fold) and oseltamivir (12.5-fold).,zanamivir,,middle,,NA(B type),152K,NA(B type),
NA(B type),152N,PMID:28802866,Table 2 of the original text mentions that the NA substitution K152N reduced sensitivity to oseltamivir (5.5-fold) and laninamivir (2.1-fold).,oseltamivir,,middle,,NA(B type),152N,NA(B type),
NA(B type),152N,PMID:28802866,Table 2 of the original text mentions that the NA substitution K152N reduced sensitivity to oseltamivir (5.5-fold) and laninamivir (2.1-fold).,laninamivir,,low,,NA(B type),152N,NA(B type),
NA(B type),154K,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution R154K exhibits reduced sensitivity to zanamivir (7.3-fold).,zanamivir,,middle,,NA(B type),154K,NA(B type),
NA(B type),197N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution D197N exhibits reduced sensitivity to zanamivir (5-fold), oseltamivir (5-fold) and peramivir (18-fold).",oseltamivir,,low,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution D197N exhibits reduced sensitivity to zanamivir (5-fold), oseltamivir (5-fold) and peramivir (18-fold).",zanamivir,,low,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution D197N exhibits reduced sensitivity to zanamivir (5-fold), oseltamivir (5-fold) and peramivir (18-fold).",peramivir,,middle,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution D197N reduced sensitivity to oseltamivir (4.8-7.2-fold), zanamivir (4.0-5.2-fold), peramivir (5.4-24.0-fold) and laninamivir (2.0-3.0-fold).",oseltamivir,,low,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution D197N reduced sensitivity to oseltamivir (4.8-7.2-fold), zanamivir (4.0-5.2-fold), peramivir (5.4-24.0-fold) and laninamivir (2.0-3.0-fold).",zanamivir,,low,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution D197N reduced sensitivity to oseltamivir (4.8-7.2-fold), zanamivir (4.0-5.2-fold), peramivir (5.4-24.0-fold) and laninamivir (2.0-3.0-fold).",peramivir,,middle,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:28802866,"Table 2 of the original text mentions that the NA substitution D197N reduced sensitivity to oseltamivir (4.8-7.2-fold), zanamivir (4.0-5.2-fold), peramivir (5.4-24.0-fold) and laninamivir (2.0-3.0-fold).",laninamivir,,low,,NA(B type),197N,NA(B type),
NA(B type),197N,PMID:30771405,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,NA(B type),197N,NA(B type),
NA(B type),198E,PMID:16801417,Table 4 of the original text mentions that the NA mutation D198E reduced sensitivity to oseltamivir (26.3-fold) and zanamivir (6.7-fold).,oseltamivir,,middle,,NA(B type),198E,NA(B type),
NA(B type),198E,PMID:16801417,Table 4 of the original text mentions that the NA mutation D198E reduced sensitivity to oseltamivir (26.3-fold) and zanamivir (6.7-fold).,zanamivir,,middle,,NA(B type),198E,NA(B type),
NA(B type),200T,PMID:32004620,"NA A200T showed HRI by peramivir and RI by oseltamivir and zanamivir with the substitution being detected in the clinical specimen.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A200T exhibits reduced sensitivity to oseltamivir (24-fold), zanamivir (19-fold), peramivir (67-fold) and laninamivir (2.7-fold).",oseltamivir,,middle,,NA(B type),200T,NA(B type),
NA(B type),200T,PMID:32004620,"NA A200T showed HRI by peramivir and RI by oseltamivir and zanamivir with the substitution being detected in the clinical specimen.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A200T exhibits reduced sensitivity to oseltamivir (24-fold), zanamivir (19-fold), peramivir (67-fold) and laninamivir (2.7-fold).",zanamivir,,middle,,NA(B type),200T,NA(B type),
NA(B type),200T,PMID:32004620,"NA A200T showed HRI by peramivir and RI by oseltamivir and zanamivir with the substitution being detected in the clinical specimen.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A200T exhibits reduced sensitivity to oseltamivir (24-fold), zanamivir (19-fold), peramivir (67-fold) and laninamivir (2.7-fold).",peramivir,,high,,NA(B type),200T,NA(B type),
NA(B type),200T,PMID:32004620,"NA A200T showed HRI by peramivir and RI by oseltamivir and zanamivir with the substitution being detected in the clinical specimen.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A200T exhibits reduced sensitivity to oseltamivir (24-fold), zanamivir (19-fold), peramivir (67-fold) and laninamivir (2.7-fold).",laninamivir,,low,,NA(B type),200T,NA(B type),
NA(B type),221L,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221L exhibits reduced sensitivity to zanamivir (20-fold), oseltamivir (98-fold) and peramivir (39-fold).",oseltamivir,,high,,NA(B type),221L,NA(B type),
NA(B type),221L,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221L exhibits reduced sensitivity to zanamivir (20-fold), oseltamivir (98-fold) and peramivir (39-fold).",zanamivir,,middle,,NA(B type),221L,NA(B type),
NA(B type),221L,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221L exhibits reduced sensitivity to zanamivir (20-fold), oseltamivir (98-fold) and peramivir (39-fold).",peramivir,,middle,,NA(B type),221L,NA(B type),
NA(B type),221N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221N exhibits reduced sensitivity to zanamivir (6-fold), oseltamivir (36-fold) and peramivir (136-fold).",oseltamivir,,middle,,NA(B type),221N,NA(B type),
NA(B type),221N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221N exhibits reduced sensitivity to zanamivir (6-fold), oseltamivir (36-fold) and peramivir (136-fold).",zanamivir,,middle,,NA(B type),221N,NA(B type),
NA(B type),221N,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221N exhibits reduced sensitivity to zanamivir (6-fold), oseltamivir (36-fold) and peramivir (136-fold).",peramivir,,high,,NA(B type),221N,NA(B type),
NA(B type),221T,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221T exhibits reduced sensitivity to oseltamivir (5-fold) and peramivir (10-fold).,oseltamivir,,low,,NA(B type),221T,NA(B type),
NA(B type),221T,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221T exhibits reduced sensitivity to oseltamivir (5-fold) and peramivir (10-fold).,peramivir,,middle,,NA(B type),221T,NA(B type),
NA(B type),221T,PMID:28802866,"Table 2 of the original text mentions that the NA substitution I221T reduced sensitivity to zanamivir (2.2-fold), peramivir (7.6-fold) and laninamivir (2.6-fold).",zanamivir,,low,,NA(B type),221T,NA(B type),
NA(B type),221T,PMID:28802866,"Table 2 of the original text mentions that the NA substitution I221T reduced sensitivity to zanamivir (2.2-fold), peramivir (7.6-fold) and laninamivir (2.6-fold).",peramivir,,middle,,NA(B type),221T,NA(B type),
NA(B type),221T,PMID:28802866,"Table 2 of the original text mentions that the NA substitution I221T reduced sensitivity to zanamivir (2.2-fold), peramivir (7.6-fold) and laninamivir (2.6-fold).",laninamivir,,low,,NA(B type),221T,NA(B type),
NA(B type),221V,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution I221V exhibits reduced sensitivity to peramivir (6-fold).,peramivir,,middle,,NA(B type),221V,NA(B type),
NA(B type),221V,PMID:28802866,Table 2 of the original text mentions that the NA substitution K152N reduced sensitivity to oseltamivir (5.5-fold) and laninamivir (2.1-fold).,peramivir,,middle,,NA(B type),221V,NA(B type),
NA(B type),221V,PMID:28802866,Table 2 of the original text mentions that the NA substitution K152N reduced sensitivity to oseltamivir (5.5-fold) and laninamivir (2.1-fold).,laninamivir,,low,,NA(B type),221V,NA(B type),
NA(B type),222T,PMID:16801417,Table 4 of the original text mentions that the NA mutation I222T reduced sensitivity to oseltamivir (13.4-fold) and zanamivir (6.5-fold).,oseltamivir,,middle,,NA(B type),222T,NA(B type),
NA(B type),222T,PMID:16801417,Table 4 of the original text mentions that the NA mutation I222T reduced sensitivity to oseltamivir (13.4-fold) and zanamivir (6.5-fold).,zanamivir,,middle,,NA(B type),222T,NA(B type),
NA(B type),243D,PMID:35292289,"A different substitution at this residue, NA-G243D, conferred RI/HRI by oseltamivir and zanamivir; data not available for the other two NAIs.",oseltamivir,,middle,,NA(B type),243D,NA(B type),
NA(B type),243D,PMID:35292289,"A different substitution at this residue, NA-G243D, conferred RI/HRI by oseltamivir and zanamivir; data not available for the other two NAIs.",zanamivir,,high,,NA(B type),243D,NA(B type),
NA(B type),243G,PMID:28802866,Table 2 of the original text mentions that the NA substitution G243S/G reduced sensitivity to oseltamivir (4.5-fold) and zanamivir (6.1-fold).,oseltamivir,,low,,NA(B type),243G,NA(B type),
NA(B type),243G,PMID:28802866,Table 2 of the original text mentions that the NA substitution G243S/G reduced sensitivity to oseltamivir (4.5-fold) and zanamivir (6.1-fold).,zanamivir,,middle,,NA(B type),243G,NA(B type),
NA(B type),243S,PMID:28802866,Table 2 of the original text mentions that the NA substitution G243S/G reduced sensitivity to oseltamivir (4.5-fold) and zanamivir (6.1-fold).,oseltamivir,,low,,NA(B type),243S,NA(B type),
NA(B type),243S,PMID:28802866,Table 2 of the original text mentions that the NA substitution G243S/G reduced sensitivity to oseltamivir (4.5-fold) and zanamivir (6.1-fold).,zanamivir,,middle,,NA(B type),243S,NA(B type),
NA(B type),245T,PMID:32004620,"A245T showed HRI by zanamivir and RI by oseltamivir and peramivir but patient information was unavailable.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A245T exhibits reduced sensitivity to oseltamivir (8.8-fold), zanamivir (205-fold), peramivir (10-fold) and laninamivir (4.8-fold).",oseltamivir,,middle,,NA(B type),245T,NA(B type),
NA(B type),245T,PMID:32004620,"A245T showed HRI by zanamivir and RI by oseltamivir and peramivir but patient information was unavailable.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A245T exhibits reduced sensitivity to oseltamivir (8.8-fold), zanamivir (205-fold), peramivir (10-fold) and laninamivir (4.8-fold).",zanamivir,,high,,NA(B type),245T,NA(B type),
NA(B type),245T,PMID:32004620,"A245T showed HRI by zanamivir and RI by oseltamivir and peramivir but patient information was unavailable.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A245T exhibits reduced sensitivity to oseltamivir (8.8-fold), zanamivir (205-fold), peramivir (10-fold) and laninamivir (4.8-fold).",peramivir,,middle,,NA(B type),245T,NA(B type),
NA(B type),245T,PMID:32004620,"A245T showed HRI by zanamivir and RI by oseltamivir and peramivir but patient information was unavailable.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution A245T exhibits reduced sensitivity to oseltamivir (8.8-fold), zanamivir (205-fold), peramivir (10-fold) and laninamivir (4.8-fold).",laninamivir,,low,,NA(B type),245T,NA(B type),
NA(B type),264V,PMID:25043638,Table 2 of the original text mentions that the NA substitution E264V reduced sensitivity to peramivir (6.9-8.1-fold).,peramivir,,middle,,NA(B type),264V,NA(B type),
NA(B type),270K,PMID:32004620,"Two further variants displaying two polymorphisms (NA G104R/G and NA D432G/D) or NA R270K substitution showed RI by peramivir and zanamivir, respectively, and polymorphism/substitution was not detected in the clinical specimens.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution R270K exhibits reduced sensitivity to zanamivir (17-fold), peramivir (3.9-fold) and laninamivir (3.4-fold).",zanamivir,,middle,,NA(B type),270K,NA(B type),
NA(B type),270K,PMID:32004620,"Two further variants displaying two polymorphisms (NA G104R/G and NA D432G/D) or NA R270K substitution showed RI by peramivir and zanamivir, respectively, and polymorphism/substitution was not detected in the clinical specimens.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution R270K exhibits reduced sensitivity to zanamivir (17-fold), peramivir (3.9-fold) and laninamivir (3.4-fold).",peramivir,,low,,NA(B type),270K,NA(B type),
NA(B type),270K,PMID:32004620,"Two further variants displaying two polymorphisms (NA G104R/G and NA D432G/D) or NA R270K substitution showed RI by peramivir and zanamivir, respectively, and polymorphism/substitution was not detected in the clinical specimens.Table 2 of the original text mentions that the virus B/Victoria-lineage with NA substitution R270K exhibits reduced sensitivity to zanamivir (17-fold), peramivir (3.9-fold) and laninamivir (3.4-fold).",laninamivir,,low,,NA(B type),270K,NA(B type),
NA(B type),273Y,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution H273Y exhibits reduced sensitivity to oseltamivir (3-fold) and peramivir (30-fold).,oseltamivir,,low,,NA(B type),273Y,NA(B type),
NA(B type),273Y,PMID:31790712,Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution H273Y exhibits reduced sensitivity to oseltamivir (3-fold) and peramivir (30-fold).,peramivir,,middle,,NA(B type),273Y,NA(B type),
NA(B type),273Y,PMID:28802866,Table 2 of the original text mentions that the NA substitution H273Y reduced sensitivity to oseltamivir (4.6-6.1-fold) and peramivir (99.0-134.0-fold).,oseltamivir,,low,,NA(B type),273Y,NA(B type),
NA(B type),273Y,PMID:28802866,Table 2 of the original text mentions that the NA substitution H273Y reduced sensitivity to oseltamivir (4.6-6.1-fold) and peramivir (99.0-134.0-fold).,peramivir,,high,,NA(B type),273Y,NA(B type),
NA(B type),294S,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution N294S exhibits reduced sensitivity to zanamivir (3-fold), oseltamivir (8-fold) and peramivir (17-fold).",oseltamivir,,middle,,NA(B type),294S,NA(B type),
NA(B type),294S,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution N294S exhibits reduced sensitivity to zanamivir (3-fold), oseltamivir (8-fold) and peramivir (17-fold).",zanamivir,,low,,NA(B type),294S,NA(B type),
NA(B type),294S,PMID:31790712,"Table 2 of the original text mentions that the BR/08 (Victoria-lineage) with NA substitution N294S exhibits reduced sensitivity to zanamivir (3-fold), oseltamivir (8-fold) and peramivir (17-fold).",peramivir,,middle,,NA(B type),294S,NA(B type),
NA(B type),340D,PMID:32406800,"According to the binding free energy calculation, the N340D and E358K substitutions reduced the affinity of oseltamivir to neuraminidase.",oseltamivir,,low,,NA(B type),340D,NA(B type),
NA(B type),348T,PMID:32004620,NA I348T substitution was detected in a hospitalized patient and showed borderline RI by oseltamivir and zanamivir.,oseltamivir,,middle,,NA(B type),348T,NA(B type),
NA(B type),348T,PMID:32004620,NA I348T substitution was detected in a hospitalized patient and showed borderline RI by oseltamivir and zanamivir.,zanamivir,,middle,,NA(B type),348T,NA(B type),
NA(B type),358K,PMID:32406800,"According to the binding free energy calculation, the N340D and E358K substitutions reduced the affinity of oseltamivir to neuraminidase.",oseltamivir,,low,,NA(B type),358K,NA(B type),
NA(B type),396H,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution L396H exhibits reduced sensitivity to oseltamivir (2.8-fold) and zanamivir (11-fold).,oseltamivir,,low,,NA(B type),396H,NA(B type),
NA(B type),396H,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution L396H exhibits reduced sensitivity to oseltamivir (2.8-fold) and zanamivir (11-fold).,zanamivir,,middle,,NA(B type),396H,NA(B type),
NA(B type),407S,PMID:30882323,"B/Quebec/1182C/2018 demonstrated reduced inhibition (RI; 5- to 50-fold increases in IC50 over wild-type) (4) to oseltamivir, zanamivir, and peramivir, showing 5.97-, 32.44-, and 38.34-fold increases in IC50s, respectively, over B/Quebec/88855/2018 WT",oseltamivir,,middle,,NA(B type),407S,NA(B type),
NA(B type),407S,PMID:30882323,"B/Quebec/1182C/2018 demonstrated reduced inhibition (RI; 5- to 50-fold increases in IC50 over wild-type) (4) to oseltamivir, zanamivir, and peramivir, showing 5.97-, 32.44-, and 38.34-fold increases in IC50s, respectively, over B/Quebec/88855/2018 WT",zanamivir,,middle,,NA(B type),407S,NA(B type),
NA(B type),407S,PMID:30882323,"B/Quebec/1182C/2018 demonstrated reduced inhibition (RI; 5- to 50-fold increases in IC50 over wild-type) (4) to oseltamivir, zanamivir, and peramivir, showing 5.97-, 32.44-, and 38.34-fold increases in IC50s, respectively, over B/Quebec/88855/2018 WT",peramivir,,middle,,NA(B type),407S,NA(B type),
NA(B type),407S,PMID:31790712,Table 2 of the original text mentions that the PH/13 (Yamagata-lineage) with NA substitution G407S exhibits reduced sensitivity to oseltamivir (3-fold).,oseltamivir,,low,,NA(B type),407S,NA(B type),
NA(B type),430L,PMID:31323237,"In NA inhibition assays, oseltamivir, zanamivir and peramivir IC50s of the Val430Ile isolate were 4-, 15- and 16-fold higher compared to a wild-type (WT) strain.",oseltamivir,,low,,NA(B type),430L,NA(B type),
NA(B type),430L,PMID:31323237,"In NA inhibition assays, oseltamivir, zanamivir and peramivir IC50s of the Val430Ile isolate were 4-, 15- and 16-fold higher compared to a wild-type (WT) strain.",zanamivir,,middle,,NA(B type),430L,NA(B type),
NA(B type),430L,PMID:31323237,"In NA inhibition assays, oseltamivir, zanamivir and peramivir IC50s of the Val430Ile isolate were 4-, 15- and 16-fold higher compared to a wild-type (WT) strain.",peramivir,,middle,,NA(B type),430L,NA(B type),
NA(B type),431R,PMID:32750469,Please refer to Table 2 of the original article for the specific fold change values.,oseltamivir,,low,,NA(B type),431R,NA(B type),
NA(B type),431R,PMID:32750469,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,middle,,NA(B type),431R,NA(B type),
NA(B type),431R,PMID:32750469,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,high,,NA(B type),431R,NA(B type),
NA(B type),432G,PMID:28802866,Table 2 of the original text mentions that the NA substitution D432G reduced sensitivity to peramivir (23.0-54.0-fold).,peramivir,,middle,,NA(B type),432G,NA(B type),
NA(B type),432N,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution D432N exhibits reduced sensitivity to peramivir (8.1-fold).,peramivir,,middle,,NA(B type),432N,NA(B type),
NA(B type),436P,PMID:32750469,Please refer to Table 2 of the original article for the specific fold change values.,zanamivir,,low,,NA(B type),436P,NA(B type),
NA(B type),436P,PMID:32750469,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,NA(B type),436P,NA(B type),
NA(B type),436P,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution T436P exhibits reduced sensitivity to peramivir (9.8-fold).,peramivir,,middle,,NA(B type),436P,NA(B type),
NA(B type),438L,PMID:32750469,"The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",oseltamivir,,middle,,NA(B type),438L,NA(B type),
NA(B type),438L,PMID:32750469,"The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",zanamivir,,middle,,NA(B type),438L,NA(B type),
NA(B type),438L,PMID:32750469,"The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",peramivir,,middle,,NA(B type),438L,NA(B type),
NA(B type),438R,PMID:32750469,"The purified W438R was highly resistant to all three NAIs, with IC50 values > 450 nM. The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",oseltamivir,,middle,,NA(B type),438R,NA(B type),
NA(B type),438R,PMID:32750469,"The purified W438R was highly resistant to all three NAIs, with IC50 values > 450 nM. The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",zanamivir,,high,,NA(B type),438R,NA(B type),
NA(B type),438R,PMID:32750469,"The purified W438R was highly resistant to all three NAIs, with IC50 values > 450 nM. The R438L was less resistant, but still demonstrated >10-fold resistance to zanamivir and peramivir.",peramivir,,high,,NA(B type),438R,NA(B type),
NA(B type),464T,PMID:30771405,Please refer to Table 2 of the original article for the specific fold change values.,peramivir,,middle,,NA(B type),464T,NA(B type),
NA(B type),464T,PMID:32004620,Table 2 of the original text mentions that the virus B/Yamagata-lineage with NA substitution M464T exhibits reduced sensitivity to peramivir (7.7-fold).,peramivir,,middle,,NA(B type),464T,NA(B type),
PA,119D,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgA/WSN/33-PA/E119D reduced sensitivity to baloxavir (6.46-fold).,baloxavir,,low,,PA,119D,PA,
PA,119D,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,119D,PA,
PA,199G,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgA/Victoria/3/75-PA/E199G reduced sensitivity to baloxavir (4.46-fold).,baloxavir,,low,,PA,199G,PA,
PA,199G,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,199G,PA,
PA,199G,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,199G,PA,
PA,23G,PMID:32574689,Table 3 of the original text mentions that the PA  mutation E23G in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (6.9-fold).,baloxavir,,low,,PA,23G,PA,
PA,23G,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,23G,PA,
PA,23G,PMID:30670144,"Analysis of PA sequences of 6,891 influenza A and B viruses collected during 2016/17 and 2017/18 seasons showed amino acid substitutions: I38L (two A(H1N1)pdm09 viruses), E23G (two A(H1N1)pdm09 viruses) and I38M (one A(H3N2) virus); conferring 4-10-fold reduced susceptibility to baloxavir.",baloxavir,,low,,PA,23G,PA,
PA,23K,PMID:32574689,Table 3 of the original text mentions that the PA  mutation I38T in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (11.4–32.2-fold).,baloxavir,,low,,PA,23K,PA,
PA,23K,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,23K,PA,
PA,23K,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,23K,PA,
PA,28P,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgA/Victoria/3/75-PA/L28P reduced sensitivity to baloxavir (2.58-fold).,baloxavir,,low,,PA,28P,PA,
PA,34R,PMID:31541547,Table 3 of the original text mentions that the PA mutation K34R in virus A(H3N2) reduced sensitivity to baloxavir (4.1-fold).,baloxavir,,low,,PA,34R,PA,
PA,36V,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgA/WSN/33-PA/A36V reduced sensitivity to baloxavir (3.59-fold).,baloxavir,,low,,PA,36V,PA,
PA,36V,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,36V,PA,
PA,37T,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgA/Victoria/3/75-PA/A37T reduced sensitivity to baloxavir (8.13-fold).,baloxavir,,low,,PA,37T,PA,
PA,37T,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,37T,PA,
PA,37T,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,37T,PA,
PA,38F,PMID:32574689,Table 3 of the original text mentions that the PA  mutation I38F/I mix in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (2.5-fold).,baloxavir,,low,,PA,38F,PA,
PA,38F,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,38F,PA,
PA,38F,PMID:30771405,"The substitutions PAN/I38T, PAN/I38M and PAN/I38F in an A(H1N1)pdm09 viruses had a 65, 23 and 17 fold increases in EC50 compared to respective wild type viruses, respectively,",baloxavir,,middle,,PA,38F,PA,
PA,38I,PMID:32574689,Table 3 of the original text mentions that the PA  mutation I38F/I mix in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (2.5-fold).,baloxavir,,low,,PA,38I,PA,
PA,38L,PMID:31541547,Please refer to Table 2 of the original article for the specific fold change values.,baloxavir,,low,,PA,38L,PA,
PA,38L,PMID:30670144,Please refer to Table 1 of the original article for the specific fold change values.,baloxavir,,low,,PA,38L,PA,
PA,38M,PMID:31541547,Please refer to Table 2 of the original article for the specific fold change values.,baloxavir,,low,,PA,38M,PA,
PA,38M,PMID:30771405,"The substitutions PAN/I38T, PAN/I38M and PAN/I38F in an A(H1N1)pdm09 viruses had a 65, 23 and 17 fold increases in EC50 compared to respective wild type viruses, respectively,",baloxavir,,middle,,PA,38M,PA,
PA,38N,PMID:32253432,Please refer to Supplemental Table 1 of the original article for the specific fold change values.,baloxavir,,middle,,PA,38N,PA,
PA,38S,PMID:32574689,Table 3 of the original text mentions that the PA  mutation I38T in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (11.4–32.2-fold).,baloxavir,,middle,,PA,38S,PA,
PA,38T,PMID:32574689,Table 3 of the original text mentions that the PA mutation I38T in virus A(H1N1)pdm09 reduced sensitivity to baloxavir (11.4–32.2-fold).,baloxavir,,middle,,PA,38T,PA,
PA,38T,PMID:31436527,The mutant virus encoding the PA I38T substitution showed normal inhibition with all 4 NA inhibitors but exhibited a 186-fold higher IC50 value (236 nmol/L) to baloxavir compared with the median IC50 value of influenza A(H3N2) viruses isolated in the 2018–19 season in Japan.,baloxavir,,high,,PA,38T,PA,
PA,38T,PMID:31541547,"To our knowledge, the effect of I38S on susceptibility has not yet been reported. The I38T in A(H3N2) background conferred the highest EC50 (153.8 nM), leading to 116-fold decrease in baloxavir susceptibility.",baloxavir,,high,,PA,38T,PA,
PA,38T,PMID:30771405,"The substitutions PAN/I38T, PAN/I38M and PAN/I38F in an A(H1N1)pdm09 viruses had a 65, 23 and 17 fold increases in EC50 compared to respective wild type viruses, respectively,",baloxavir,,middle,,PA,38T,PA,
PA,38V,PMID:29941893,Table 1 of the original text mentions that the PA mutationrg A/WSN/33-PA/I38V reduced sensitivity to baloxavir (2.18-fold).,baloxavir,,low,,PA,38V,PA,
PA(B type),23K,PMID:32343991,"The I38T, I38M and E23K substitutions increased BXA IC50s values by 12.6-, 5.5-, and 2.6-fold, respectively, compared to the WT.",baloxavir,,low,,PA(B type),23K,PA(B type),
PA(B type),38F,PMID:29941893,Table 1 of the original text mentions that the PA mutation rgB/Maryland/1/59-PA/I38F reduced sensitivity to baloxavir (2.39-fold).,baloxavir,,low,,PA(B type),38F,PA(B type),
PA(B type),38M,PMID:32343991,"The I38T, I38M and E23K substitutions increased BXA IC50s values by 12.6-, 5.5-, and 2.6-fold, respectively, compared to the WT.",baloxavir,,middle,,PA(B type),38M,PA(B type),
PA(B type),38T,PMID:32343991,"The I38T, I38M and E23K substitutions increased BXA IC50s values by 12.6-, 5.5-, and 2.6-fold, respectively, compared to the WT.",baloxavir,,middle,,PA(B type),38T,PA(B type),
